JPH04316523A - Optically active dodecane derivative - Google Patents
Optically active dodecane derivativeInfo
- Publication number
- JPH04316523A JPH04316523A JP10853591A JP10853591A JPH04316523A JP H04316523 A JPH04316523 A JP H04316523A JP 10853591 A JP10853591 A JP 10853591A JP 10853591 A JP10853591 A JP 10853591A JP H04316523 A JPH04316523 A JP H04316523A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- configuration
- optically active
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- SNRUBQQJIBEYMU-NJFSPNSNSA-N dodecane Chemical class CCCCCCCCCCC[14CH3] SNRUBQQJIBEYMU-NJFSPNSNSA-N 0.000 title abstract description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 62
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 30
- 150000001721 carbon Chemical group 0.000 claims abstract description 19
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 13
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 13
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims abstract description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 19
- 125000005843 halogen group Chemical group 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 125000005079 alkoxycarbonylmethyl group Chemical group 0.000 claims 1
- -1 diene compound Chemical class 0.000 abstract description 150
- 239000000126 substance Substances 0.000 abstract description 35
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 abstract description 18
- BLUHKGOSFDHHGX-UHFFFAOYSA-N Phytol Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C=CO BLUHKGOSFDHHGX-UHFFFAOYSA-N 0.000 abstract description 18
- HNZBNQYXWOLKBA-UHFFFAOYSA-N Tetrahydrofarnesol Natural products CC(C)CCCC(C)CCCC(C)=CCO HNZBNQYXWOLKBA-UHFFFAOYSA-N 0.000 abstract description 18
- BOTWFXYSPFMFNR-OALUTQOASA-N all-rac-phytol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)=CCO BOTWFXYSPFMFNR-OALUTQOASA-N 0.000 abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 17
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 abstract description 13
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 abstract description 12
- 239000000543 intermediate Substances 0.000 abstract description 9
- 229930003633 citronellal Natural products 0.000 abstract description 6
- 235000000983 citronellal Nutrition 0.000 abstract description 6
- 239000007858 starting material Substances 0.000 abstract description 6
- 229910052736 halogen Inorganic materials 0.000 abstract description 3
- 150000002367 halogens Chemical class 0.000 abstract description 3
- JGUOUUUTXGGCGA-GCZGVDRJSA-N methyl (2e,5r)-5,9-dimethyldeca-2,8-dienoate Chemical compound COC(=O)\C=C\C[C@H](C)CCC=C(C)C JGUOUUUTXGGCGA-GCZGVDRJSA-N 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 113
- 239000000243 solution Substances 0.000 description 63
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 53
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 50
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 47
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 46
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 44
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 40
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 40
- 239000002904 solvent Substances 0.000 description 40
- 229920006395 saturated elastomer Polymers 0.000 description 39
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 36
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 35
- 239000000203 mixture Substances 0.000 description 32
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 31
- 238000004440 column chromatography Methods 0.000 description 23
- 239000000741 silica gel Substances 0.000 description 23
- 229910002027 silica gel Inorganic materials 0.000 description 23
- 238000005160 1H NMR spectroscopy Methods 0.000 description 22
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 22
- 238000002360 preparation method Methods 0.000 description 21
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 20
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 20
- 235000019341 magnesium sulphate Nutrition 0.000 description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 19
- 229910001873 dinitrogen Inorganic materials 0.000 description 19
- 238000010898 silica gel chromatography Methods 0.000 description 19
- 229910052786 argon Inorganic materials 0.000 description 18
- 239000011261 inert gas Substances 0.000 description 18
- 150000002148 esters Chemical class 0.000 description 15
- 238000000034 method Methods 0.000 description 15
- 239000011780 sodium chloride Substances 0.000 description 15
- 239000004593 Epoxy Substances 0.000 description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 229910052739 hydrogen Inorganic materials 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 11
- 238000001816 cooling Methods 0.000 description 11
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 10
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 8
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 8
- 150000002366 halogen compounds Chemical class 0.000 description 8
- 229910052740 iodine Inorganic materials 0.000 description 8
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 239000012280 lithium aluminium hydride Substances 0.000 description 7
- JSPLKZUTYZBBKA-UHFFFAOYSA-N trioxidane Chemical compound OOO JSPLKZUTYZBBKA-UHFFFAOYSA-N 0.000 description 7
- NEHNMFOYXAPHSD-SNVBAGLBSA-N (+)-Citronellal Chemical compound O=CC[C@H](C)CCC=C(C)C NEHNMFOYXAPHSD-SNVBAGLBSA-N 0.000 description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 229930040373 Paraformaldehyde Natural products 0.000 description 6
- 238000007865 diluting Methods 0.000 description 6
- 229920002866 paraformaldehyde Polymers 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 235000019270 ammonium chloride Nutrition 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 125000001309 chloro group Chemical group Cl* 0.000 description 5
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 5
- 230000002140 halogenating effect Effects 0.000 description 5
- 150000002576 ketones Chemical class 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical class [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 239000000010 aprotic solvent Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 150000001805 chlorine compounds Chemical class 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 4
- 230000003595 spectral effect Effects 0.000 description 4
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 description 4
- QJNLUNBGDFUULX-UHFFFAOYSA-N 4-n,4-n'-dimethyl-3h-pyridine-4,4-diamine Chemical compound CNC1(NC)CC=NC=C1 QJNLUNBGDFUULX-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000000908 ammonium hydroxide Substances 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- NDQXKKFRNOPRDW-UHFFFAOYSA-N 1,1,1-triethoxyethane Chemical compound CCOC(C)(OCC)OCC NDQXKKFRNOPRDW-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 239000012419 sodium bis(2-methoxyethoxy)aluminum hydride Substances 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- QMBQEXOLIRBNPN-UHFFFAOYSA-L zirconocene dichloride Chemical compound [Cl-].[Cl-].[Zr+4].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 QMBQEXOLIRBNPN-UHFFFAOYSA-L 0.000 description 2
- PFODYVTXEFDXQP-DPTWWRMPSA-N (11z,14z)-heptadeca-1,11,14-triene-8,9-diol Chemical compound CC\C=C/C\C=C/CC(O)C(O)CCCCCC=C PFODYVTXEFDXQP-DPTWWRMPSA-N 0.000 description 1
- WHWDWIHXSPCOKZ-IAGOWNOFSA-N (6r,10r)-6,10,14-trimethylpentadecan-2-one Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCCC(C)=O WHWDWIHXSPCOKZ-IAGOWNOFSA-N 0.000 description 1
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- BQKXESNVJFWTOY-UHFFFAOYSA-N 2-methyl-1-(2-methylpropoxy)propane;titanium Chemical compound [Ti].CC(C)COCC(C)C BQKXESNVJFWTOY-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 238000005821 Claisen rearrangement reaction Methods 0.000 description 1
- FEWJPZIEWOKRBE-LWMBPPNESA-L D-tartrate(2-) Chemical compound [O-]C(=O)[C@@H](O)[C@H](O)C([O-])=O FEWJPZIEWOKRBE-LWMBPPNESA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- 101000582320 Homo sapiens Neurogenic differentiation factor 6 Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 102100030589 Neurogenic differentiation factor 6 Human genes 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical class [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 1
- LCKIEQZJEYYRIY-UHFFFAOYSA-N Titanium ion Chemical compound [Ti+4] LCKIEQZJEYYRIY-UHFFFAOYSA-N 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- FXRDDHAARFQORE-UHFFFAOYSA-N [2-(2-methylpropyl)cyclohexyl] acetate Chemical compound CC(C)CC1CCCCC1OC(C)=O FXRDDHAARFQORE-UHFFFAOYSA-N 0.000 description 1
- JEDZLBFUGJTJGQ-UHFFFAOYSA-N [Na].COCCO[AlH]OCCOC Chemical compound [Na].COCCO[AlH]OCCOC JEDZLBFUGJTJGQ-UHFFFAOYSA-N 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000012320 chlorinating reagent Substances 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 238000006880 cross-coupling reaction Methods 0.000 description 1
- MKNXBRLZBFVUPV-UHFFFAOYSA-L cyclopenta-1,3-diene;dichlorotitanium Chemical compound Cl[Ti]Cl.C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 MKNXBRLZBFVUPV-UHFFFAOYSA-L 0.000 description 1
- IDASTKMEQGPVRR-UHFFFAOYSA-N cyclopenta-1,3-diene;zirconium(2+) Chemical compound [Zr+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 IDASTKMEQGPVRR-UHFFFAOYSA-N 0.000 description 1
- 238000005695 dehalogenation reaction Methods 0.000 description 1
- VWWMOACCGFHMEV-UHFFFAOYSA-N dicarbide(2-) Chemical compound [C-]#[C-] VWWMOACCGFHMEV-UHFFFAOYSA-N 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000006735 epoxidation reaction Methods 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- XXROGKLTLUQVRX-UHFFFAOYSA-N hydroxymethylethylene Natural products OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 1
- UWNADWZGEHDQAB-UHFFFAOYSA-N i-Pr2C2H4i-Pr2 Natural products CC(C)CCC(C)C UWNADWZGEHDQAB-UHFFFAOYSA-N 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- 230000001035 methylating effect Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- JJYKJUXBWFATTE-UHFFFAOYSA-N mosher's acid Chemical compound COC(C(O)=O)(C(F)(F)F)C1=CC=CC=C1 JJYKJUXBWFATTE-UHFFFAOYSA-N 0.000 description 1
- IDSMDKUVIBSETN-UHFFFAOYSA-N n-methyl-n-(propan-2-ylideneamino)methanamine Chemical compound CN(C)N=C(C)C IDSMDKUVIBSETN-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- XUYJLQHKOGNDPB-UHFFFAOYSA-N phosphonoacetic acid Chemical compound OC(=O)CP(O)(O)=O XUYJLQHKOGNDPB-UHFFFAOYSA-N 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 150000003458 sulfonic acid derivatives Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000005147 toluenesulfonyl group Chemical group C=1(C(=CC=CC1)S(=O)(=O)*)C 0.000 description 1
- KJIOQYGWTQBHNH-UHFFFAOYSA-N undecanol Chemical class CCCCCCCCCCCO KJIOQYGWTQBHNH-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、光学活性なドデカン誘
導体、その中間体及びそれらの製造方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to optically active dodecane derivatives, intermediates thereof, and methods for producing them.
【0002】0002
【従来の技術】天然フィトールは、後記実施例15に構
造式を示すように、光学活性な化合物であり、種々の医
薬品又は農薬の中間原料、特にはビタミンEの中間原料
として有用である。従来技術においては、光学活性なフ
ィトールを、天然物、例えば植物の葉等から抽出して入
手していたので、品質や収率にばらつきがあった。また
、従来の化学合成法では、キラリティの制御が困難であ
り、光学分割を必要とした。BACKGROUND OF THE INVENTION Natural phytol is an optically active compound, as shown in the structural formula in Example 15 below, and is useful as an intermediate raw material for various pharmaceuticals or agricultural chemicals, particularly for vitamin E. In the prior art, optically active phytol was obtained by extracting it from natural products such as plant leaves, resulting in variations in quality and yield. Furthermore, with conventional chemical synthesis methods, it was difficult to control chirality, and optical resolution was required.
【0003】0003
【発明が解決しようとする課題】本発明の目的は、入手
が容易な光学活性出発材料・シトロネラールを用い、そ
のキラリティーを保存したままで純度100%eeの中
間体化合物を経て、純度100%eeのフィトールを容
易に合成することのできる手段を提供することにある。[Problems to be Solved by the Invention] The purpose of the present invention is to use an easily available optically active starting material, citronellal, to obtain a product with a purity of 100% ee through an intermediate compound with a purity of 100% ee while preserving its chirality. The object of the present invention is to provide a means by which phytol of ee can be easily synthesized.
【0004】0004
【課題を解決するための手段】前記の目的は、本発明に
より、一般式(I)[Means for Solving the Problems] According to the present invention, the above-mentioned object is achieved by
【0005】[0005]
【化5】[C5]
【0006】〔式中、R1 、R2 、R3 及びR4
はそれぞれ独立に炭素数1〜4個の低級アルキル基(
例えば、メチル基、エチル基、プロピル基又はブチル基
)であり、R5 は一般式(I’)
−C(A)=C(B)−E
(I’)(式中、Aはハロゲン原子、例えば、塩素原子
、臭素原子又はヨウ素原子であるか又はBと一緒になっ
て炭素−炭素直接結合であり、Bは水素原子又はAと一
緒になって炭素−炭素直接結合であり、Eは水素原子又
は炭素数1〜4個のヒドロキシ低級アルキル基、例えば
、ヒドロキシメチル基又はヒドロキシエチル基である)
で表される基であり、そして式中で*を付したキラル中
心炭素原子における立体配置はそれぞれ独立に択一的に
S−配置又はR−配置のいずれか一方の配置のみをとる
ものとする〕で表される化合物によって達成することが
できる。[In the formula, R1, R2, R3 and R4
each independently represents a lower alkyl group having 1 to 4 carbon atoms (
For example, methyl group, ethyl group, propyl group or butyl group), and R5 is of the general formula (I') -C(A)=C(B)-E
(I') (wherein A is a halogen atom, such as a chlorine atom, a bromine atom or an iodine atom, or together with B is a direct carbon-carbon bond, and B is a hydrogen atom or together with A (E is a hydrogen atom or a hydroxy lower alkyl group having 1 to 4 carbon atoms, such as a hydroxymethyl group or a hydroxyethyl group)
is a group represented by the formula, and the configuration at the chiral central carbon atom marked with * in the formula shall each independently and alternatively take only one of the S-configuration and R-configuration. ] This can be achieved by a compound represented by:
【0007】また、本発明は、前記の化合物を製造する
方法を提供するものでもある。その製造方法は以下の工
程(a)〜工程(t)からなる。The present invention also provides a method for producing the above-mentioned compound. The manufacturing method consists of the following steps (a) to (t).
【0008】(a)一般式( XII)(a) General formula (XII)
【0009】[0009]
【化6】[C6]
【0010】(式中、R1 、R2 、R3 及び*は
前記と同じ意味である)で表されるジエン化合物の一方
の二重結合を位置かつエチンチオ選択的にエポキシ化し
て一般式(IIa)[0010] One double bond of the diene compound represented by the formula (wherein R1, R2, R3 and * have the same meanings as above) is regio- and ethynthio-selectively epoxidized to obtain the general formula (IIa).
【0011】[0011]
【化7】[C7]
【0012】(式中、R1 、R2 、R3 及び*は
前記と同じ意味である)で表される相当する(即ち、立
体配置を保存して)光学活性なヒドロキシエポキシ化合
物を得る工程。A step of obtaining an optically active hydroxyepoxy compound represented by the formula (in which R1, R2, R3 and * have the same meanings as above) (that is, while preserving the steric configuration).
【0013】(b)一般式(IIa)で表される光学活
性なヒドロキシエポキシ化合物をスルホン酸誘導体(例
えば、スルホン酸クロリド)で処理して、一般式(II
b)(b) The optically active hydroxyepoxy compound represented by the general formula (IIa) is treated with a sulfonic acid derivative (for example, sulfonic acid chloride) to form the optically active hydroxyepoxy compound represented by the general formula (IIa).
b)
【0014】[0014]
【化8】[Chemical formula 8]
【0015】(式中、X21はヒドロキシ基を脱離基と
することのできる基、好ましくは、パラトルエンスルホ
ニル基又はメタンスルホニル基であり、R1 、R2
、R3 及び*は前記と同じ意味である)で表される相
当する(即ち、立体配置を保存して)光学活性なスルホ
ン酸エステル化されたエポキシ化合物を得る工程。(wherein, X21 is a group capable of using a hydroxyl group as a leaving group, preferably a para-toluenesulfonyl group or a methanesulfonyl group,
, R3 and * have the same meanings as above) (that is, while preserving the configuration), obtaining an optically active sulfonic acid esterified epoxy compound.
【0016】(c)一般式(IIb)で表される光学活
性な保護ヒドロキシエポキシ化合物をハロゲン化剤で処
理して、一般式(IIc)(c) The optically active protected hydroxyepoxy compound represented by general formula (IIb) is treated with a halogenating agent to form general formula (IIc).
【0017】[0017]
【化9】[Chemical formula 9]
【0018】(式中、X22はハロゲン原子、例えば、
塩素原子、臭素原子又はヨウ素原子であり、R1 、R
2 、R3 及び*は前記と同じ意味である)で表され
る相当する(即ち、立体配置を保存して)光学活性なハ
ロゲン化エポキシ化合物を得る工程。(In the formula, X22 is a halogen atom, for example,
A chlorine atom, a bromine atom or an iodine atom, and R1, R
2, R3 and * have the same meanings as above) A step of obtaining an optically active halogenated epoxy compound (that is, preserving the configuration).
【0019】(d)前記工程(b)及び工程(c)の二
段階法に代わる以下の一段階法、即ち、一般式(IIa
)で表される光学活性なヒドロキシエポキシ化合物をハ
ロゲン化剤で処理して、一般式(IIc)で表される相
当する(即ち、立体配置を保存して)光学活性なハロゲ
ン化エポキシ化合物を得る工程。(d) Instead of the two-step method of steps (b) and (c), the following one-step method is used, namely, the general formula (IIa
) is treated with a halogenating agent to obtain a corresponding optically active halogenated epoxy compound represented by general formula (IIc) (i.e., preserving the configuration) Process.
【0020】(e)一般式(IIc)で表される光学活
性なハロゲン化エポキシ化合物を強塩基で処理して、一
般式( IIIa)(e) The optically active halogenated epoxy compound represented by general formula (IIc) is treated with a strong base to form general formula (IIIa).
【0021】[0021]
【化10】[Chemical formula 10]
【0022】(式中、R1 、R2 、R3 及び*は
前記と同じ意味である)で表される相当する(即ち、立
体配置を保存して)光学活性なヒドロキシアルキン化合
物を得る工程。A step of obtaining an optically active hydroxyalkyne compound represented by the formula (in which R1, R2, R3 and * have the same meanings as above) (that is, while preserving the steric configuration).
【0023】(f)一般式( IIIa)で表される光
学活性なヒドロキシアルキン化合物をトリアルキルシリ
ル化剤で処理して、一般式( IIIb)(f) An optically active hydroxyalkyne compound represented by general formula (IIIa) is treated with a trialkylsilylating agent to form general formula (IIIb).
【0024】[0024]
【化11】[Chemical formula 11]
【0025】〔式中、X31はヒドロキシ基を保護する
基、好ましくは、炭素数1〜4個の低級アルキル基で置
換されているシリル基(例えば、t−ブチルジメチルシ
リル基)であり、R1 、R2 、R3 及び*は前記
と同じ意味である〕で表される相当する(即ち、立体配
置を保存して)光学活性な保護ヒドロキシアルキン化合
物を得る工程。[In the formula, , R2, R3 and * have the same meanings as above] (that is, while preserving the steric configuration) to obtain an optically active protected hydroxyalkyne compound.
【0026】(g)一般式( IIIb)で表される光
学活性な保護ヒドロキシアルキン化合物をアルキル化剤
で処理して、一般式( IIIc)(g) The optically active protected hydroxyalkyne compound represented by general formula (IIIb) is treated with an alkylating agent to form general formula (IIIc).
【0027】[0027]
【化12】[Chemical formula 12]
【0028】(式中、X31、R1 、R2 、R3
、R4 及び*は前記と同じ意味である)で表される相
当する(即ち、立体配置を保存して)光学活性なアルキ
ル化アルキン化合物を得る工程。(wherein, X31, R1, R2, R3
, R4 and * have the same meanings as above) (that is, while preserving the steric configuration) to obtain an optically active alkylated alkyne compound.
【0029】(h)一般式( IIIc)で表される光
学活性なアルキル化アルキン化合物を脱シリル化剤で処
理して、一般式( IIId)(h) The optically active alkylated alkyne compound represented by the general formula (IIIc) is treated with a desilylating agent to form the general formula (IIId).
【0030】[0030]
【化13】[Chemical formula 13]
【0031】(式中、R1 、R2 、R3 、R4
及び*は前記と同じ意味である)で表される相当する(
即ち、立体配置を保存して)光学活性なアルキル化ヒド
ロキシアルキン化合物を得る工程。(In the formula, R1, R2, R3, R4
and * have the same meaning as above).
That is, a step of obtaining an optically active alkylated hydroxyalkyne compound while preserving the steric configuration.
【0032】(i)一般式( IIId)で表される光
学活性なアルキル化アルキン化合物を還元剤で処理して
、一般式( IIIe)(i) The optically active alkylated alkyne compound represented by the general formula (IIId) is treated with a reducing agent to form the general formula (IIIe).
【0033】[0033]
【化14】[Chemical formula 14]
【0034】(式中、R1 、R2 、R3 、R4
及び*は前記と同じ意味である)で表される相当する(
即ち、立体配置を保存して)光学活性なアルキル化ヒド
ロキシ−シス又はトランス配置のアルケン化合物を得る
工程。(In the formula, R1, R2, R3, R4
and * have the same meaning as above).
That is, a step of obtaining an optically active alkylated hydroxy-cis- or trans-configured alkene compound (with steric configuration preserved).
【0035】(j)一般式( IIIe)で表される光
学活性なアルキル化ヒドロキシアルケン化合物をオルト
酢酸エステルで処理して、一般式(IV)(j) An optically active alkylated hydroxyalkene compound represented by general formula (IIIe) is treated with orthoacetic ester to form general formula (IV).
【0036】[0036]
【化15】[Chemical formula 15]
【0037】(式中、R41は炭素数1〜4個の低級ア
ルキル基、例えば、前記基R1 に関して列挙した基で
あり、R1 、R2 、R3 、R4 及び*は前記と
同じ意味である)で表される相当する(即ち、立体配置
を保存して)光学活性なγ,δ−不飽和エステル化合物
を得る工程。(wherein R41 is a lower alkyl group having 1 to 4 carbon atoms, for example, the group listed for the group R1 above, and R1, R2, R3, R4 and * have the same meanings as above) A step of obtaining an optically active γ,δ-unsaturated ester compound corresponding to (ie, preserving the configuration) as shown.
【0038】(k)一般式(IV)で表される光学活性
なγ,δ−不飽和エステル化合物を還元して、一般式(
V)(k) The optically active γ,δ-unsaturated ester compound represented by the general formula (IV) is reduced to form the general formula (
V)
【0039】[0039]
【化16】[Chemical formula 16]
【0040】(式中、R41、R1 、R2 、R3
、R4 及び*は前記と同じ意味である)で表される相
当する(即ち、立体配置を保存して)光学活性な飽和エ
ステル化合物を得る工程。(In the formula, R41, R1, R2, R3
, R4 and * have the same meanings as above) (that is, while preserving the steric configuration) to obtain an optically active saturated ester compound.
【0041】(l)一般式(V)で表される光学活性な
飽和エステル化合物をリチウムアルミニウムハイドライ
ドで処理して、一般式(VI)(l) The optically active saturated ester compound represented by general formula (V) is treated with lithium aluminum hydride to form general formula (VI).
【0042】[0042]
【化17】[Chemical formula 17]
【0043】(式中、R1 、R2 、R3 、R4
及び*は前記と同じ意味である)で表される相当する(
即ち、立体配置を保存して)光学活性な飽和アルコール
化合物を得る工程。(In the formula, R1, R2, R3, R4
and * have the same meaning as above).
That is, a step of obtaining an optically active saturated alcohol compound while preserving the steric configuration.
【0044】(m)一般式(VI)で表される光学活性
な飽和アルコール化合物をハロゲン化剤で処理して、一
般式(VII )(m) An optically active saturated alcohol compound represented by general formula (VI) is treated with a halogenating agent to form general formula (VII).
【0045】[0045]
【化18】[Chemical formula 18]
【0046】(式中、X71はハロゲン原子、好ましく
は塩素原子、臭素原子又はヨウ素原子であり、R1 、
R2 、R3、R4 及び*は前記と同じ意味である)
で表される相当する(即ち、立体配置を保存して)光学
活性な飽和ハロゲン化合物を得る工程。(In the formula, X71 is a halogen atom, preferably a chlorine atom, a bromine atom or an iodine atom, and R1,
R2, R3, R4 and * have the same meanings as above)
A step of obtaining an optically active saturated halogen compound represented by (that is, preserving the configuration).
【0047】(n)一般式(VII )で表される光学
活性な飽和ハロゲン化合物をアセトソn,n−ジメチル
ヒドラゾンで処理して、一般式(VIII)(n) An optically active saturated halogen compound represented by general formula (VII) is treated with acetoso n,n-dimethylhydrazone to form general formula (VIII).
【0048
】0048
]
【化19】[Chemical formula 19]
【0049】(式中、R1 、R2 、R3 、R4
及び*は前記と同じ意味である)で表される相当する(
即ち、立体配置を保存して)光学活性なケトン化合物を
得る工程。(In the formula, R1, R2, R3, R4
and * have the same meaning as above).
That is, a step of obtaining an optically active ketone compound while preserving the steric configuration.
【0050】(o)一般式(VIII)で表される光学
活性なケトン化合物をハロゲン化剤で処理して、一般式
(Ia)(o) An optically active ketone compound represented by general formula (VIII) is treated with a halogenating agent to form general formula (Ia).
【0051】[0051]
【化20】[C20]
【0052】(式中、X11はハロゲン原子、例えば、
塩素原子、臭素原子又はヨウ素原子であり、R1 、R
2 、R3 、R4 及び*は前記と同じ意味である)
で表される相当する(即ち、立体配置を保存して)光学
活性なアルケン化合物を得る工程。(In the formula, X11 is a halogen atom, for example,
A chlorine atom, a bromine atom or an iodine atom, and R1, R
2, R3, R4 and * have the same meanings as above)
A step of obtaining an optically active alkene compound corresponding to (that is, preserving the configuration) represented by
【0053】(p)一般式(Ia)で表される光学活性
なアルケン化合物を強塩基で処理して、一般式(Ib)
(p) The optically active alkene compound represented by general formula (Ia) is treated with a strong base to form general formula (Ib).
【0054】[0054]
【化21】[C21]
【0055】(式中、R1 、R2 、R3 、R4
及び*は前記と同じ意味である)で表される相当する(
即ち、立体配置を保存して)光学活性なアルキン化合物
を得る工程。(In the formula, R1, R2, R3, R4
and * have the same meaning as above).
That is, a step of obtaining an optically active alkyne compound while preserving the steric configuration.
【0056】(q)一般式(Ib)で表される光学活性
なアルキン化合物を強塩基存在下にパラホルムアルデヒ
ドで処理して、一般式(Ic)(q) An optically active alkyne compound represented by general formula (Ib) is treated with paraformaldehyde in the presence of a strong base to form general formula (Ic).
【0057】[0057]
【化22】[C22]
【0058】(式中、R1 、R2 、R3 、R4
及び*は前記と同じ意味である)で表される相当する(
即ち、立体配置を保存して)光学活性なヒドロキシアル
キル化アルキン化合物を得る工程。(In the formula, R1, R2, R3, R4
and * have the same meaning as above).
That is, a step of obtaining an optically active hydroxyalkylated alkyne compound while preserving the steric configuration.
【0059】(r)一般式(Ic)で表される光学活性
なヒドロキシアルキル化アルキン化合物をアルミニウム
水素化物〔例えば、ナトリウムビス(2−メトキシエト
キシ)アルミニウムヒドリド〕、次いでハロゲン、例え
ば、ヨウ素で処理して、一般式(Id)(r) An optically active hydroxyalkylated alkyne compound represented by general formula (Ic) is treated with aluminum hydride [for example, sodium bis(2-methoxyethoxy)aluminum hydride] and then with a halogen, for example, iodine. Then, the general formula (Id)
【0060】[0060]
【化23】[C23]
【0061】(式中、X12はハロゲン原子、例えば、
塩素原子、臭素原子又はヨウ素原子であり、R1 、R
2 、R3 、R4 及び*は前記と同じ意味である)
で表される相当する(即ち、立体配置を保存して)光学
活性なハロゲン化アルケン化合物を得る工程。(In the formula, X12 is a halogen atom, for example,
A chlorine atom, a bromine atom or an iodine atom, and R1, R
2, R3, R4 and * have the same meanings as above)
A step of obtaining an optically active halogenated alkene compound corresponding to (that is, preserving the configuration) represented by
【0062】(s)一般式(Id)で表される光学活性
なハロゲン化アルケン化合物をリチウムジアルキルキュ
ーポレートで処理して、一般式(IX)(s) An optically active halogenated alkene compound represented by general formula (Id) is treated with lithium dialkyl cuporate to form general formula (IX).
【0063】[0063]
【化24】[C24]
【0064】(式中、R91は炭素数1〜4個の低級ア
ルキル基、例えば、前記基R1 に関して列挙した基で
あり、R1 、R2 、R3 、R4 及び*は前記と
同じ意味である)で表される相当する(即ち、立体配置
を保存して)光学活性なフィトール化合物を得る工程。(wherein R91 is a lower alkyl group having 1 to 4 carbon atoms, for example, the group listed for the group R1 above, and R1, R2, R3, R4 and * have the same meanings as above) A step of obtaining an optically active phytol compound corresponding to (ie, preserving the configuration) as shown.
【0065】(t)前記工程(q)〜工程(s)の三段
階法に代えて以下の一段階法、即ち、一般式(Ib)で
表される光学活性なアルキン化合物をメタロセンクロリ
ド(例えば、ジルコノセンジクロリド又はチタノセンジ
クロリド)とトリアルキルアルミニウム(例えば、トリ
メチルアルミニウム)との混合物で処理し、次いでアル
キルリチウム(例えば、n−ブチルリチウム)で処理し
、更にカルボニル化合物(例えば、パラホルムアルデヒ
ド)で処理して、一般式(IX)で表される相当する(
即ち、立体配置を保存して)光学活性なフィトール化合
物を得る工程。(t) Instead of the three-step method of steps (q) to (s), the following one-step method is used: an optically active alkyne compound represented by the general formula (Ib) is mixed with a metallocene chloride (for example, , zirconocene dichloride or titanocene dichloride) and a trialkylaluminum (e.g. trimethylaluminum), followed by treatment with an alkyllithium (e.g. n-butyllithium) and further treatment with a carbonyl compound (e.g. paraformaldehyde). Then, the corresponding (
That is, a step of obtaining an optically active phytol compound while preserving the steric configuration.
【0066】以下、前記の工程(a)〜工程(t)を順
に説明する。
工程(a)
出発材料である一般式( XII)で表されるジエン化
合物は公知の化合物であり、公知の光学活性シトロネラ
ール化合物から公知の方法により、その立体配置を保存
して調製することができる。このジエン化合物( XI
I)のエポキシ化は、例えば、不活性ガス(例えば、ア
ルゴン又は窒素ガス)雰囲気下で、低温下(例えば、−
30〜0℃、特には−15〜−10℃)にて、非プロト
ン性溶媒(例えば、塩化メチレン)中で、l(−)又は
d(−)酒石酸エステルと、チタニウムイソブチルオキ
シド2−ジブチルハイドロパーオキサイドを用い、4a
モレキュラーシーブの存在下で実施することができる。
この工程(a)において、出発材料・ジエン化合物(
XII)における1個のキラル中心炭素原子の立体配置
は変化せずに、ヒドロキシエポキシ化合物(IIa)に
そのまま保存される。また、新たにエポキシ基結合部位
に2個のキラル中心が生成される。これらのキラル中心
炭素原子の立体配置は、出発材料・ジエン化合物(XI
I)に存在するキラル中心炭素原子の立体配置に対して
、これとは関係なく形成させることができる。得られた
ヒドロキシエポキシ化合物(IIa)を必要により精製
(例えば、シリカゲルカラムクロマトグラフィー処理)
して次の工程(b)に用いる。[0066] Hereinafter, the above steps (a) to (t) will be explained in order. Step (a) The starting material, the diene compound represented by general formula (XII), is a known compound, and can be prepared from a known optically active citronellal compound by a known method while preserving its steric configuration. . This diene compound (XI
The epoxidation of I) can be carried out, for example, under an inert gas (e.g. argon or nitrogen gas) atmosphere at low temperatures (e.g. -
l(-) or d(-) tartrate and titanium isobutyl oxide 2-dibutylhydro in an aprotic solvent (e.g. methylene chloride) at 30-0°C, especially -15--10°C). Using peroxide, 4a
It can be carried out in the presence of molecular sieves. In this step (a), the starting material/diene compound (
The configuration of one chiral central carbon atom in XII) remains unchanged in the hydroxyepoxy compound (IIa). Furthermore, two chiral centers are newly generated at the epoxy group bonding site. The configuration of these chiral central carbon atoms is determined by the starting material/diene compound (XI
It can be formed independently of the configuration of the chiral central carbon atom present in I). The obtained hydroxyepoxy compound (IIa) is purified as necessary (for example, by silica gel column chromatography treatment)
and used in the next step (b).
【0067】工程(b)
ヒドロキシ基の保護基導入剤としては、スルホン酸エス
テル化剤、例えば、パラトルエンスルホニウムクロリド
を用いることができる。この反応は、例えば、不活性ガ
ス(例えば、アルゴン又は窒素ガス)雰囲気下で、常温
下(例えば、−10℃〜室温、特には室温)にて、非プ
ロトン性溶媒(例えば、塩基メチレン)中で、パラトル
エンスルホニウムクロリドを用い、トリエチルアミン及
び4,4−ジメチルアミノピリジンの存在下で実施する
ことができる。この工程(b)において、ヒドロキシエ
ポキシ化合物(IIa)における3個のキラル中心炭素
原子の立体配置は変化せずに、保護ヒドロキシエポキシ
化合物(IIb)にそのまま保存される。得られた保護
ヒドロキシエポキシ化合物(IIb)を必要により精製
(例えば、シリカゲルカラムクロマトグラフィー処理)
して次の工程(c)に用いる。Step (b) As the hydroxy group-protecting group-introducing agent, a sulfonic acid esterifying agent such as para-toluenesulfonium chloride can be used. This reaction can be carried out, for example, in an aprotic solvent (e.g. the base methylene) at room temperature (e.g. -10°C to room temperature, especially room temperature) under an inert gas (e.g. argon or nitrogen gas) atmosphere. can be carried out using para-toluenesulfonium chloride in the presence of triethylamine and 4,4-dimethylaminopyridine. In this step (b), the steric configuration of the three chiral central carbon atoms in the hydroxyepoxy compound (IIa) remains unchanged in the protected hydroxyepoxy compound (IIb). The obtained protected hydroxyepoxy compound (IIb) is purified if necessary (e.g., silica gel column chromatography treatment)
and used in the next step (c).
【0068】工程(c)
ハロゲン化剤としては、例えば、塩化リチウムを用いる
ことができる。この反応は、不活性ガス(例えば、アル
ゴン又は窒素ガス)雰囲気下で、常温乃至高温下(例え
ば、室温 〜100℃、特には50〜80℃)にて、
非プロトン性極性溶媒(例えば、ジメチルホルムアミド
)中で実施することができる。この工程(c)において
、保護ヒドロキシエポキシ化合物(IIb)における3
個のキラル中心炭素原子の立体配置は変化せずに、ハロ
ゲン化エポキシ化合物(IIc)にそのまま保存される
。得られたハロゲン化エポキシ化合物(IIc)を必要
により精製(例えば、シリカゲルカラムクロマトグラフ
ィー処理)して次の工程(e)に用いる。Step (c) As the halogenating agent, for example, lithium chloride can be used. This reaction is carried out under an inert gas (e.g., argon or nitrogen gas) atmosphere at room temperature to high temperature (e.g., room temperature to 100°C, particularly 50 to 80°C).
It can be carried out in an aprotic polar solvent such as dimethylformamide. In this step (c), 3 in the protected hydroxyepoxy compound (IIb)
The configuration of the chiral central carbon atoms remains unchanged in the halogenated epoxy compound (IIc). The obtained halogenated epoxy compound (IIc) is purified if necessary (for example, by silica gel column chromatography treatment) and used in the next step (e).
【0069】工程(d)
ヒドロキシエポキシ化合物(IIa)から、前記工程(
b)及び工程(c)の二段階法に代えて、一段階法でハ
ロゲン化エポキシ化合物(IIc)を得ることができる
。この反応は、例えば、不活性ガス(例えば、アルゴン
又は窒素ガス)雰囲気下で、高温下(例えば、50〜1
00℃、特には60〜80℃)にて、クロル化剤となる
溶媒(例えば、四塩化炭素)中で、トリフェニルホスフ
ィンを用いて実施することができる。この工程(d)に
おいて、ヒドロキシエポキシ化合物(IIa)における
3個のキラル中心炭素原子の立体配置は変化せずに、ハ
ロゲン化エポキシ化合物(IIc)にそのまま保存され
る。得られたハロゲン化エポキシ化合物(IIc)を必
要により精製(例えば、シリカゲルカラムクロマトグラ
フィー処理)して次の工程(e)に用いる。Step (d) From the hydroxyepoxy compound (IIa) to the above step (
Instead of the two-step process of b) and step (c), the halogenated epoxy compound (IIc) can be obtained by a one-step process. This reaction is carried out, for example, under an inert gas (e.g. argon or nitrogen gas) atmosphere and at high temperatures (e.g. 50-1
It can be carried out using triphenylphosphine in a solvent (e.g. carbon tetrachloride) serving as a chlorinating agent at a temperature of 00°C, particularly 60-80°C. In this step (d), the configuration of the three chiral center carbon atoms in the hydroxyepoxy compound (IIa) is not changed and is preserved as it is in the halogenated epoxy compound (IIc). The obtained halogenated epoxy compound (IIc) is purified if necessary (for example, by silica gel column chromatography treatment) and used in the next step (e).
【0070】工程(e)
脱離反応は、例えば、不活性ガス(例えば、アルゴン又
は窒素ガス)雰囲気下で、低温下(例えば、−70〜0
℃、特には−40〜−20℃)にて、エーテル性溶媒(
例えば、テトラヒドロフラン)中で、n−ブチルリチウ
ムを用いて実施することができる。この工程(e)にお
いて、ハロゲン化エポキシ化合物(IIc)における3
個のキラル中心の内の1個が消滅するが、残りの2個の
キラル中心炭素原子の立体配置は変化せずに、ヒドロキ
シアルキン化合物( IIIa)にそのまま保存される
。得られたヒドロキシアルキン化合物( IIIa)を
必要により精製(例えば、シリカゲルカラムクロマトグ
ラフィー処理)して次の工程(f)に用いる。Step (e) The elimination reaction is performed, for example, in an inert gas (for example, argon or nitrogen gas) atmosphere at a low temperature (for example, from -70 to 0
℃, especially -40 to -20℃), an ethereal solvent (
For example, it can be carried out using n-butyllithium in tetrahydrofuran). In this step (e), 3 in the halogenated epoxy compound (IIc)
One of the chiral centers disappears, but the configuration of the remaining two chiral center carbon atoms remains unchanged in the hydroxyalkyne compound (IIIa). The obtained hydroxyalkyne compound (IIIa) is purified if necessary (eg, silica gel column chromatography treatment) and used in the next step (f).
【0071】工程(f)
ヒドロキシ基の保護基導入剤としては、例えば、t−ブ
チルジメチルシリルクロリドを用いることができる。こ
の反応は、例えば、不活性ガス(例えば、アルゴン又は
窒素ガス)雰囲気下で、常温下(例えば、0〜40℃、
特には室温)にて、非プロトン性溶媒(例えば、塩化メ
チル)中で、トリエチルアミンを用い、4,4−アミノ
ジメチルピリジンの存在下で実施することができる。こ
の工程(f)において、ヒドロキシアルキン化合物(
IIIa)における2個のキラル中心炭素原子の立体配
置は変化せずに、保護ヒドロキシアルキン化合物( I
IIb)にそのまま保存される。得られた保護ヒドロキ
シアルキン化合物( IIIb)を必要により精製(例
えば、シリカゲルカラムクロマトグラフィー処理)して
次の工程(g)に用いる。Step (f) As the hydroxy group-protecting group-introducing agent, for example, t-butyldimethylsilyl chloride can be used. This reaction is carried out, for example, under an inert gas (e.g. argon or nitrogen gas) atmosphere at room temperature (e.g. 0 to 40°C,
It can be carried out using triethylamine in the presence of 4,4-aminodimethylpyridine in an aprotic solvent (for example methyl chloride) at room temperature. In this step (f), a hydroxyalkyne compound (
The configuration of the two chiral central carbon atoms in IIIa) remains unchanged and the protected hydroxyalkyne compound (I
IIb). The obtained protected hydroxyalkyne compound (IIIb) is purified if necessary (eg, silica gel column chromatography treatment) and used in the next step (g).
【0072】工程(g)
アルキル基導入剤としては、例えば、ヨウ化メチルを用
いることができる。この反応は、例えば、不活性ガス(
例えば、アルゴン又は窒素ガス)雰囲気下で、低温下(
例えば、−40〜0℃、特には−5〜0℃)にて、エー
テル性溶媒(例えば、テトラヒドロフラン)中で、n−
ブチルリチウムを用いてアセチリドとし、更にヨウ化メ
チルでメチル化することにより実施することができる。
この工程(g)において、保護ヒドロキシアルキン化合
物( IIIb)における2個のキラル中心炭素原子の
立体配置は変化せずに、アルキル化アルキン化合物(I
IIc)にそのまま保存される。得られたアルキル化ア
ルキン化合物( IIIc)を必要により精製(例えば
、シリカゲルカラムクロマトグラフィー処理)して次の
工程(h)に用いる。Step (g) As the alkyl group-introducing agent, for example, methyl iodide can be used. This reaction can be carried out using, for example, an inert gas (
For example, under an atmosphere of argon or nitrogen gas, and at a low temperature (
For example, n-
This can be carried out by converting it into acetylide using butyllithium and further methylating it with methyl iodide. In this step (g), the alkylated alkyne compound (I
IIc). The obtained alkylated alkyne compound (IIIc) is purified if necessary (eg, silica gel column chromatography treatment) and used in the next step (h).
【0073】工程(h)
保護基の脱離は、不活性ガス(例えば、アルゴン又は窒
素ガス)雰囲気下で、常温下(例えば、0〜60℃、特
には室温)にて、エーテル性溶媒(例えば、テトラヒド
ロフラン)中で、フッ素化塩、特にはテトラn−ブチル
アンモニウムフルオライドと攪拌又は希酸水溶剤の存在
下に攪拌することにより実施することができる。この工
程(h)において、アルキル化アルキン化合物( II
Ic)における2個のキラル中心炭素原子の立体配置は
変化せずに、アルキル化ヒドロキシアルキン化合物(
IIId)にそのまま保存される。得られたアルキル化
ヒドロキシアルキン化合物( IIId)を必要により
精製(例えば、シリカゲルカラムクロマトグラフィー処
理)して次の工程(i)に用いる。Step (h) The removal of the protecting group is carried out by using an ethereal solvent ( For example, it can be carried out by stirring with a fluorinated salt, in particular tetra n-butylammonium fluoride, in (eg, tetrahydrofuran) or in the presence of a dilute acid aqueous solvent. In this step (h), an alkylated alkyne compound (II
Ic) without changing the configuration of the two chiral central carbon atoms in the alkylated hydroxyalkyne compound (
IIId). The obtained alkylated hydroxyalkyne compound (IIId) is purified if necessary (eg, silica gel column chromatography treatment) and used in the next step (i).
【0074】工程(i)
還元剤としては、例えばリチウムアルミニウムハイドラ
イドを用いることができる。この還元反応は、不活性ガ
ス(例えば、アルゴン又は窒素ガス)雰囲気下で、常温
乃至高温下(例えば、室温〜100℃、特には70〜8
0℃)にて、エーテル性溶媒(例えば、テトラヒドロフ
ラン)中で実施することができる。この工程(i)にお
いて、アルキル化ヒドロキシアルキン化合物( III
d)における2個のキラル中心炭素原子の立体配置は変
化せずに、アルキル化ヒドロキシアルケン化合物( I
IIe)にそのまま保存される。また、この工程(i)
ではシス−トランス異性体の混合物が得られる。この混
合物を精製(例えばシリカゲルカラムクロマトグラフィ
ー処理)して次の工程(j)に用いる。Step (i) As the reducing agent, for example, lithium aluminum hydride can be used. This reduction reaction is carried out in an inert gas (e.g., argon or nitrogen gas) atmosphere at room temperature to high temperature (e.g., room temperature to 100°C, particularly 70 to 80°C).
0° C.) in an ethereal solvent (eg, tetrahydrofuran). In this step (i), an alkylated hydroxyalkyne compound (III
d) without changing the configuration of the two chiral central carbon atoms in the alkylated hydroxyalkene compound (I
IIe). Also, this step (i)
gives a mixture of cis-trans isomers. This mixture is purified (for example, by silica gel column chromatography treatment) and used in the next step (j).
【0075】工程(j)
クライゼン転移反応は、例えば、不活性ガス(例えば、
アルゴン又は窒素ガス)雰囲気下で、常温乃至高温下(
例えば、120〜180℃、特には150〜160℃)
にて、オルト酢酸エチル中又は非プロトン性溶媒中で、
セバリン酸の存在下で実施することができる。この工程
(j)において、アルキル化ヒドロキシアルケン化合物
( IIIe)における2個のキラル中心の内の1個が
消滅するが、残りの1個のキラル中心炭素原子の立体配
置は変化せずにγ,δ−不飽和エステル化合物(IV)
にそのまま保存される。また、エステルカルボニル基の
β位に新たにキラル中心が生成する。このキラル中心炭
素原子の立体配置は前駆体の水酸基のキラリティにより
決定される。得られたγ,δ−不飽和エステル化合物(
IV)を必要により精製(例えば、シリカゲルカラムク
ロマトグラフィー処理)して次の工程(k)に用いる。Step (j) The Claisen rearrangement reaction can be carried out using, for example, an inert gas (for example,
Under an atmosphere of argon or nitrogen gas, at room temperature to high temperature (
For example, 120-180°C, especially 150-160°C)
in ethyl orthoacetate or in an aprotic solvent,
It can be carried out in the presence of sevalic acid. In this step (j), one of the two chiral centers in the alkylated hydroxyalkene compound (IIIe) disappears, but the configuration of the remaining chiral center carbon atom remains unchanged and becomes γ, δ-unsaturated ester compound (IV)
It will be saved as is. Additionally, a new chiral center is generated at the β-position of the ester carbonyl group. The configuration of this chiral central carbon atom is determined by the chirality of the hydroxyl group of the precursor. The obtained γ, δ-unsaturated ester compound (
IV) is purified as necessary (for example, by silica gel column chromatography treatment) and used in the next step (k).
【0076】工程(k)
還元反応は、例えば、水素気流下に10%パラジウム触
媒の存在下でエタノール中にて室温下において実施する
ことができる。この工程(k)において、γ,δ−不飽
和エステル化合物(IV)におけるキラル中心炭素原子
の立体配置は変化せずに飽和エステル化合物(V)にそ
のまま保存される。得られた飽和エステル化合物(V)
を必要により精製(例えば、シリカゲルカラムクロマト
グラフィー処理)して次の工程(l)に用いる。Step (k) The reduction reaction can be carried out, for example, in ethanol at room temperature in the presence of a 10% palladium catalyst under a hydrogen stream. In this step (k), the steric configuration of the chiral center carbon atom in the γ,δ-unsaturated ester compound (IV) remains unchanged in the saturated ester compound (V). Obtained saturated ester compound (V)
is purified as necessary (for example, by silica gel column chromatography treatment) and used in the next step (l).
【0077】工程(l)
還元反応は、例えば、不活性ガス(例えば、アルゴン又
は窒素ガス)雰囲気下で、低温下(例えば、−10〜0
℃、特には−5〜0℃)にて、エーテル性溶媒(例えば
、テトラヒドロフラン)中で、リチウムアルミニウムハ
イドライドを用いて実施することができる。この工程(
l)において、飽和エステル化合物(V)におけるキラ
ル中心炭素原子の立体配置は変化せずに飽和アルコール
化合物(VI)にそのまま保存される。得られた飽和ア
ルコール化合物(VI)を必要により精製(例えば、シ
リカゲルカラムクロマトグラフィー処理)して次の工程
(m)に用いる。Step (l) The reduction reaction is carried out, for example, in an inert gas (for example, argon or nitrogen gas) atmosphere at a low temperature (for example, from -10 to 0
It can be carried out using lithium aluminum hydride in an ethereal solvent (e.g. tetrahydrofuran) at temperatures between -5 and 0[deg.]C. This process (
In l), the configuration of the chiral central carbon atom in the saturated ester compound (V) remains unchanged in the saturated alcohol compound (VI). The obtained saturated alcohol compound (VI) is purified if necessary (eg, silica gel column chromatography treatment) and used in the next step (m).
【0078】工程(m)
ハロゲン化反応は、例えば、不活性ガス(例えば、アル
ゴン又は窒素ガス)雰囲気下で、低温下(例えば、0〜
40℃、特には10〜30℃)にて、エーテル性溶媒(
例えば、ジエチルエーテル)中で四臭化炭素を用い、ト
リフェニルホスフィンの存在下で実施することができる
。この工程(m)において、飽和アルコール化合物(V
I)におけるキラル中心炭素原子の立体配置は変化せず
に飽和ハロゲン化合物(VII )にそのまま保存され
る。得られた飽和ハロゲン化合物(VII)を必要によ
り精製(例えば、シリカゲルカラムクロマトグラフィー
処理)して次の工程(n)に用いる。Step (m) The halogenation reaction is carried out, for example, in an inert gas (for example, argon or nitrogen gas) atmosphere at a low temperature (for example, from 0 to
An ethereal solvent (
For example, it can be carried out using carbon tetrabromide in diethyl ether) in the presence of triphenylphosphine. In this step (m), a saturated alcohol compound (V
The configuration of the chiral central carbon atom in I) remains unchanged in the saturated halogen compound (VII). The obtained saturated halogen compound (VII) is purified if necessary (eg, silica gel column chromatography treatment) and used in the next step (n).
【0079】工程(n)
アルキル化反応は、例えば、不活性ガス(例えば、アル
ゴン又は窒素ガス)雰囲気下で、低温下(例えば、−7
8〜室温、特には−78〜0℃)にて、エーテル性溶媒
(例えば、テトラヒドロフラン)中でn−ブチルリチウ
ムを用いて実施することができる。この工程(n)にお
いて、飽和ハロゲン化合物(VII )におけるキラル
中心炭素原子の立体配置は変化せずにケトン化合物(V
III)にそのまま保存される。得られたケトン化合物
(VIII)を必要により精製(例えば、シリカゲルカ
ラムクロマトグラフィー処理)して次の工程(o)に用
いる。Step (n) The alkylation reaction is performed, for example, in an inert gas (for example, argon or nitrogen gas) atmosphere at a low temperature (for example, -7
It can be carried out using n-butyllithium in an ethereal solvent (e.g. tetrahydrofuran) at temperatures ranging from 8°C to room temperature, especially from -78°C to 0°C. In this step (n), the configuration of the chiral center carbon atom in the saturated halogen compound (VII) remains unchanged and the ketone compound (V
III). The obtained ketone compound (VIII) is purified if necessary (for example, by silica gel column chromatography treatment) and used in the next step (o).
【0080】工程(o)
クロロアルケニル化反応は、例えば、不活性ガス(例え
ば、アルゴン又は窒素ガス)雰囲気下で、低温下(例え
ば、−10〜室温、特には−5〜0℃)にて、ハイドロ
カーボン溶媒(例えば、トルエン)中で、五塩化リンを
用いて実施することができる。この工程(o)において
、ケトン化合物(VIII)におけるキラル中心炭素原
子の立体配置は変化せずにアルケン化合物(Ia)にそ
のまま保存される。得られたアルケン化合物(Ia)を
必要により精製(例えば、シリカゲルカラムクロマトグ
ラフィー処理)して次の工程(p)に用いる。Step (o) The chloroalkenylation reaction is carried out, for example, under an inert gas (for example, argon or nitrogen gas) atmosphere at a low temperature (for example, -10 to room temperature, particularly -5 to 0°C). , can be carried out using phosphorus pentachloride in a hydrocarbon solvent (e.g. toluene). In this step (o), the steric configuration of the chiral central carbon atom in the ketone compound (VIII) remains unchanged in the alkene compound (Ia). The obtained alkene compound (Ia) is purified if necessary (eg, silica gel column chromatography treatment) and used in the next step (p).
【0081】工程(p)
脱ハロゲン化反応は、例えば、不活性ガス(例えば、ア
ルゴン又は窒素ガス)雰囲気下で、低温下(例えば、−
50〜室温、特には−30〜−20℃)にて、エーテル
性溶媒(例えば、テトラヒドロフラン)中で、リチウム
ジイソプロピルアミドの存在下で実施することができる
。この工程(p)において、アルケン化合物(Ia)に
おけるキラル中心炭素原子の立体配置は変化せずにアル
キン化合物(Ib)にそのまま保存される。得られたア
ルキン化合物(Ib)を必要により精製(例えば、シリ
カゲルカラムクロマトグラフィー処理)して次の工程(
q)に用いる。Step (p) The dehalogenation reaction is carried out, for example, in an inert gas (for example, argon or nitrogen gas) atmosphere at a low temperature (for example, -
It can be carried out in the presence of lithium diisopropylamide in an ethereal solvent (e.g. tetrahydrofuran) at a temperature of 50°C to room temperature, in particular -30°C to -20°C. In this step (p), the steric configuration of the chiral central carbon atom in the alkene compound (Ia) remains unchanged in the alkyne compound (Ib). The obtained alkyne compound (Ib) is purified as necessary (for example, by silica gel column chromatography treatment) and carried out in the next step (
Used for q).
【0082】工程(q)
ヒドロキシルメチル化反応は、例えば、不活性ガス(例
えば、アルゴン又は窒素ガス)雰囲気下で、低温下(例
えば、−78〜室温、特には室温)にて、エーテル性溶
媒(例えば、テトラヒドロフラン)中で、パラホルムア
ルデヒドを用い、グリニヤール試薬の存在下で実施する
ことができる。この工程(q)において、アルキン化合
物(Ib)におけるキラル中心炭素原子の立体配置は変
化せずにヒドロキシアルキル化アルキン化合物(Ic)
にそのまま保存される。得られたヒドロキシアルキル化
アルキン化合物(Ic)を必要により精製(例えば、シ
リカゲルカラムクロマトグラフィー処理)して次の工程
(r)に用いる。Step (q) The hydroxyl methylation reaction is carried out, for example, in an inert gas (for example, argon or nitrogen gas) atmosphere at a low temperature (for example, -78 to room temperature, especially room temperature) using an ethereal solvent. It can be carried out using paraformaldehyde in (eg, tetrahydrofuran) in the presence of a Grignard reagent. In this step (q), the configuration of the chiral central carbon atom in the alkyne compound (Ib) remains unchanged, and the hydroxyalkylated alkyne compound (Ic)
It will be saved as is. The obtained hydroxyalkylated alkyne compound (Ic) is purified if necessary (eg, silica gel column chromatography treatment) and used in the next step (r).
【0083】工程(r)
ヨウ素化反応は、例えば、不活性ガス(例えば、アルゴ
ン又は窒素ガス)雰囲気下で、低温下(例えば、−78
〜室温、特には0℃〜室温)にて、エーテル性溶媒(例
えば、ジエチルエーテル)中で、ヨウ素を用いて実施す
ることができる。この工程(r)において、ヒドロキシ
アルキル化アルキン化合物(Ic)におけるキラル中心
炭素原子の立体配置は変化せずにヒドロキシアルキル化
ハロアルケン化合物(Id)にそのまま保存される。得
られたヒドロキシアルキル化ハロアルケン化合物(Id
)を必要により精製(例えば、シリカゲルカラムクロマ
トグラフィー処理)して次の工程(s)に用いる。Step (r) The iodination reaction is carried out, for example, in an inert gas (for example, argon or nitrogen gas) atmosphere at a low temperature (for example, -78
It can be carried out using iodine in an ethereal solvent (e.g. diethyl ether) at ~room temperature, especially from 0<0>C to room temperature). In this step (r), the steric configuration of the chiral center carbon atom in the hydroxyalkylated alkyne compound (Ic) remains unchanged in the hydroxyalkylated haloalkene compound (Id). The resulting hydroxyalkylated haloalkene compound (Id
) is purified as necessary (for example, by silica gel column chromatography treatment) and used in the next step (s).
【0084】工程(s)
クロスカップリング反応は、例えば、不活性ガス(例え
ば、アルゴン又は窒素ガス)雰囲気下で、低温下(例え
ば、−78〜0℃、特には0℃)にて、リチウムジメチ
ルキュープレートを用いて実施することができる。この
工程(r)において、ヒドロキシアルキル化アルケン化
合物(Id)におけるキラル中心炭素原子の立体配置は
変化せずにフィトール化合物(IX)にそのまま保存さ
れる。得られたフィトール化合物(IX)を必要により
精製(例えば、シリカゲルカラムクロマトグラフィー処
理)して次の工程に用いる。Step (s) The cross-coupling reaction is carried out, for example, in an inert gas (for example, argon or nitrogen gas) atmosphere at a low temperature (for example, -78 to 0°C, particularly 0°C). It can be carried out using dimethyl curate. In this step (r), the configuration of the chiral central carbon atom in the hydroxyalkylated alkene compound (Id) remains unchanged in the phytol compound (IX). The obtained phytol compound (IX) is purified if necessary (for example, by silica gel column chromatography treatment) and used in the next step.
【0085】工程(t)
フィトール化合物(IX)は、前記工程(q)〜工程(
s)の三段階法に代えて、アルキン化合物(Ib)を、
例えば、ジルコノセンクロリドとトリメチルアルミニウ
ムの混合物で処理し、次いでn−ブチルリチウム、更に
パラホルムアルデヒドを反応させて行うことができる。
この反応は不活性ガス(例えば、アルゴン又は窒素ガス
)雰囲気下で、低温下(例えば、−10〜0℃、特には
−5〜0℃)にて、ハイドロカーボン溶媒(例えば、n
−ヘキサン)中で実施することができる。Step (t) The phytol compound (IX) is prepared in the above steps (q) to (
Instead of the three-step method of s), the alkyne compound (Ib) is
For example, it can be carried out by treating with a mixture of zirconocene chloride and trimethylaluminum, and then reacting with n-butyllithium and further with paraformaldehyde. This reaction is carried out under an inert gas (e.g. argon or nitrogen gas) atmosphere at low temperatures (e.g. -10 to 0°C, especially -5 to 0°C) in a hydrocarbon solvent (e.g. n
-hexane).
【0086】こうして得られたフィトール化合物(IX
)から出発して、例えば、特願平2−39322号明細
書に記載のエナンチオ選択的酸化方法により、光学活性
なトコフェロールを容易に製造することができる。純度
100%e.e.のキラルなフィトール化合物(IX)
は、種々の医薬品や農薬等の中間原料、特にはビタミン
Eの中間原料として有用である。The phytol compound thus obtained (IX
), optically active tocopherol can be easily produced by, for example, the enantioselective oxidation method described in Japanese Patent Application No. 2-39322. Purity 100% e. e. chiral phytol compound (IX) of
is useful as an intermediate raw material for various pharmaceuticals, agricultural chemicals, etc., especially as an intermediate raw material for vitamin E.
【0087】[0087]
【実施例】以下、実施例によって本発明を具体的に説明
するが、これらは本発明の範囲を限定するものではない
。なお、以下の実施例に示す化学式において、Tsはト
ルエンスルホニル基であり、TBSはt−ブチルジメチ
ルシリル基である。[Examples] The present invention will now be explained in detail with reference to Examples, but these are not intended to limit the scope of the present invention. In addition, in the chemical formula shown in the following examples, Ts is a toluenesulfonyl group, and TBS is a t-butyldimethylsilyl group.
【0088】実施例1:メチル(R)−(E)−5,9
−ジメチル−2,8−デカジエノエートの調製Example 1: Methyl (R)-(E)-5,9
-Preparation of dimethyl-2,8-decadienoate
【008
9】008
9]
【数1】[Math 1]
【0090】水素化ナトリウム(60%オイル分散液1
.623g,40.6ミリモル)のテトラヒドロフラン
(20ml)懸濁液に氷冷下で攪拌下にてメチルジイソ
プロピルホスホノアセテート(9.360g,40.0
4ミリモル)のテトラヒドロフラン(30ml)溶液を
10分間かけて滴下した。5分後、−40℃まで冷却し
、更に50分間攪拌した。(R)−シトロネラール(1
)(5.042g,32.7ミリモル)のテトラヒドロ
フラン(30ml)溶液を45分間かけて滴下し、更に
同温下で1時間攪拌した。室温まで昇温後、更に25分
間攪拌した。再び氷冷し、飽和炭酸水素ナトリウム水溶
液を加えた後、ジエチルエーテルを用いて希釈し、飽和
塩化ナトリウム水溶液で洗浄し、硫酸マグネシウムで乾
燥した後、滅圧下で溶媒を留去した。得られた残留物を
カラムクロマトグラフィー(シリカゲル90g)で処理
し、n−ヘキサン溶出部より無色油状のエステル体(2
)(6.220g,91%)を得た。理化学的データは
以下の通りである。Sodium hydride (60% oil dispersion 1
.. Methyl diisopropyl phosphonoacetate (9.360 g, 40.0
A solution of 4 mmol) in tetrahydrofuran (30 ml) was added dropwise over 10 minutes. After 5 minutes, the mixture was cooled to -40°C and further stirred for 50 minutes. (R)-citronellal (1
) (5.042 g, 32.7 mmol) in tetrahydrofuran (30 ml) was added dropwise over 45 minutes, and the mixture was further stirred at the same temperature for 1 hour. After raising the temperature to room temperature, the mixture was further stirred for 25 minutes. After cooling on ice again and adding saturated aqueous sodium hydrogen carbonate solution, diluting with diethyl ether, washing with saturated aqueous sodium chloride solution and drying over magnesium sulfate, the solvent was distilled off under reduced pressure. The obtained residue was treated with column chromatography (90 g of silica gel), and a colorless oily ester (2
) (6.220 g, 91%) was obtained. The physical and chemical data are as follows.
【0091】〔α〕D 28:−2.91゜(c=1.
05,CHCl3 )。
IRνmax(film)cm −1 :1730(C
=O),1655,1420,1380,1270,1
180,1040,980。
1H−NMR(CDCl3 )δ:0.90(d,3
H,J=6.4Hz,C(5)CH3 ),1.00〜
1.20(m,3H,C(5)CH及びC(6)H2
),1.58(s,3H,C(9)CH3 ),1.6
8(d,3H,J=7.0Hz,C(9)CH3 ),
1.18−2.43(m,4H,C(4)H2 及びC
(7)H2 ),3.73(s,3H,OCH3 ),
4.90−5.24(m,1H,C(8)H)5.81
(dt,1H,J=15.6,1.3Hz,C(2)H
),6.96(dt,1H,J=15.6,7.3Hz
,C(3)H)。MSm/e:210(M+ ),19
5,178,167,141,121、109,95,
69(100%)。
高分解MSm/e:
理論値 C13H12O2 (M+ ):210
.1620実測値
:210.1644。[α]D 28: -2.91° (c=1.
05, CHCl3). IRνmax (film) cm −1 : 1730 (C
=O), 1655, 1420, 1380, 1270, 1
180, 1040, 980. 1H-NMR (CDCl3) δ: 0.90 (d, 3
H, J=6.4Hz, C(5)CH3), 1.00~
1.20(m,3H,C(5)CH and C(6)H2
), 1.58 (s, 3H, C(9)CH3 ), 1.6
8(d,3H,J=7.0Hz,C(9)CH3),
1.18-2.43(m,4H,C(4)H2 and C
(7)H2), 3.73(s,3H,OCH3),
4.90-5.24 (m, 1H, C(8)H) 5.81
(dt, 1H, J=15.6, 1.3Hz, C(2)H
), 6.96 (dt, 1H, J=15.6, 7.3Hz
, C(3)H). MSm/e: 210 (M+), 19
5,178,167,141,121,109,95,
69 (100%). High resolution MSm/e: Theoretical value C13H12O2 (M+): 210
.. 1620 actual measurement value
:210.1644.
【0092】実施例2:(R)−(E)−5,9−ジメ
チル−2,8−デカジエン−1−オールの調製Example 2: Preparation of (R)-(E)-5,9-dimethyl-2,8-decadien-1-ol
【009
3】009
3]
【数2】[Math 2]
【0094】エステル体(2)(6.050g,28.
8ミリモル)のテトラヒドロフラン(80ml)溶液に
氷冷下で攪拌下にジイソブチルアルミニウムヒドリド(
13.0ml,73.0ミリモル)を滴下した。80分
後、飽和水酸化アンモニウム水溶液及び3.0N飽和水
酸化ナトリウム水溶液を滴下し、過剰の試薬及び複合体
を分解した。セライト及びジクロロメタンを加え、室温
下で更に10時間攪拌した。セライトろ過後、硫酸マグ
ネシウムで乾燥し、減圧下で溶媒を留去した。残留物を
カラムクロマトグラフィー(シリカゲル128g)で処
理し、ジエチルエーテル/n−ヘキサン〔1:8(v/
v)〕溶出部より無色油状のアルコール体(3)(4.
696g;90%)を得た。理化学的データは以下の通
りである。Ester (2) (6.050g, 28.
diisobutylaluminum hydride (8 mmol) in tetrahydrofuran (80 ml) was stirred under ice-cooling.
13.0 ml, 73.0 mmol) was added dropwise. After 80 minutes, saturated ammonium hydroxide aqueous solution and 3.0N saturated sodium hydroxide aqueous solution were added dropwise to decompose excess reagent and complex. Celite and dichloromethane were added, and the mixture was further stirred at room temperature for 10 hours. After filtering through Celite, it was dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was treated with column chromatography (128 g of silica gel) and treated with diethyl ether/n-hexane [1:8 (v/
v)] Colorless oily alcohol (3) (4.
696g; 90%) was obtained. The physical and chemical data are as follows.
【0095】〔α〕D 30:+1.02゜(c=1.
03,CHCl3 )。
IRνmax(film)cm −1 :3320(O
H),1455,1440,1380,1085,10
00,970。
1H−NMR(CDCl3 )δ:0.89(d,3
H,J=6.1Hz,C(5)CH3 ),0.90−
2.40(m,8H,1H,D2 Oで交換可能),1
.60(br.s.3H,C(9)CH3 ),1.6
9(br.s,3H,C(9)CH3 ),3.95−
4.23(m,2H,C(1)H2 OH),4.92
−5.24(m,1H,C(8)H),5.52−5.
80(m,2H,C(2)H及びC(3)H)。
MSm/e:183(M+ +1),182(M+ )
,164(M+ −H2O),149,138,124
,109,95,69(100%)。
高分解MSm/e:
理論値 C12H20(M+ −H2O):16
4.1565。
実測値
:164.1546。[α]D 30: +1.02° (c=1.
03, CHCl3). IRνmax (film) cm −1 :3320(O
H), 1455, 1440, 1380, 1085, 10
00,970. 1H-NMR (CDCl3) δ: 0.89 (d, 3
H, J=6.1Hz, C(5)CH3), 0.90-
2.40 (can be replaced with m, 8H, 1H, D2O), 1
.. 60 (br.s.3H, C(9)CH3), 1.6
9(br.s,3H,C(9)CH3),3.95-
4.23 (m, 2H, C(1)H2OH), 4.92
-5.24 (m, 1H, C(8)H), 5.52-5.
80 (m, 2H, C(2)H and C(3)H). MSm/e: 183 (M+ +1), 182 (M+)
,164(M+-H2O),149,138,124
, 109, 95, 69 (100%). High resolution MSm/e: Theoretical value C12H20(M+ -H2O): 16
4.1565. Actual value
:164.1546.
【0096】実施例3:(2S,3S,5R)−2,3
−エポキシ−5,9−ジメチル−8−デセン−1−オー
ルの調製Example 3: (2S,3S,5R)-2,3
- Preparation of epoxy-5,9-dimethyl-8-decen-1-ol
【0097】[0097]
【数3】[Math 3]
【0098】4A分子ふるい(2.003g)のジクロ
ロメタン(50ml)懸濁液に、−30℃で攪拌下にて
(L)−(+)酒石酸ジイソブチルエステル(1.28
ml,6.09ミリモル)及びチタン(IV)イソプロ
ホキシド(1.81ml,6.08モル)を順に加えた
。25分後、t−ブチルハイドロパーオキサイド(1.
76Mジクロロメタン溶液:4.10ml,7.22ミ
リモル)を滴下した後、同温下で更に1時間攪拌した。
アリルアルコール体(3)(1.053g,5.78ミ
リモル)のジクロロメタン(20ml)溶液を30分間
かけて滴下し、更に11時間同温下で攪拌した。3M炭
酸カリウム水溶液(2.0ml)を加えた後、室温まで
昇温し、更に1時間攪拌した。セライトを加え、更に1
時間攪拌した。セライトろ過後、減圧下で溶媒を留去し
た。残留物をカラムクロマトグラフィー(シリカゲル8
5g)で処理し、ジエチルエーテル−n−ヘキサン〔1
:4(v/v)〕溶出部より無色油状のエポキシアルコ
ール体(4)(1.116g,97%)を得た。この標
記化合物により誘導したα−トリフロロメチル−α−メ
トキシフェニル酢酸エステルの1H−NMRスペクトル
の解析により原料の(R)−シトロネラール(1)に由
来するメチル基のキラリティーに関しては71%d.e
.で、新しく形成されたエボキシ部のキラリティーに関
しては90%d.e.であることを確認した。理化学的
データは以下の通りである。To a suspension of 4A molecular sieve (2.003 g) in dichloromethane (50 ml) was added (L)-(+) tartrate diisobutyl ester (1.28 g) with stirring at -30°C.
ml, 6.09 mmol) and titanium(IV) isoprofoxide (1.81 ml, 6.08 mol) were added in sequence. After 25 minutes, t-butyl hydroperoxide (1.
After dropping a 76M dichloromethane solution (4.10 ml, 7.22 mmol), the mixture was further stirred at the same temperature for 1 hour. A solution of allyl alcohol compound (3) (1.053 g, 5.78 mmol) in dichloromethane (20 ml) was added dropwise over 30 minutes, and the mixture was further stirred at the same temperature for 11 hours. After adding a 3M aqueous potassium carbonate solution (2.0 ml), the mixture was heated to room temperature and stirred for an additional hour. Add celite and 1 more
Stir for hours. After filtering through Celite, the solvent was distilled off under reduced pressure. The residue was purified by column chromatography (silica gel 8
diethyl ether-n-hexane [1
:4 (v/v)] A colorless oily epoxy alcohol (4) (1.116 g, 97%) was obtained from the eluate. Analysis of the 1H-NMR spectrum of α-trifluoromethyl-α-methoxyphenylacetate induced by this title compound revealed that the chirality of the methyl group derived from the raw material (R)-citronellal (1) was 71% d. e
.. The chirality of the newly formed epoxy moiety is 90% d. e. It was confirmed that The physical and chemical data are as follows.
【0099】〔α〕D 29:−30.67゜(c=1
.02,CHCl3 )。
IRνmax(film)cm −1 :3430(O
H),1460,1450,1380,900。
1H−NMR(CDCl3 )δ: 0.96(d
,3H,J=6.3Hz,C(5)H3 ),0.90
−2.13(m,8H,1H D2 Oで交換可能)
,1.61(s,3H,C(9)CH3 ),1.68
(d,3H,J=1.2Hz,C(9)CH3 ),2
.75−3.12(m,2H,C(2)H及びC(3)
H),3.63(ddd,1H,J=12.6,7.1
,3.9Hz,C(1)H),3.94(ddd,1H
,J=12.6,6.0,2.5,Hz,C(1)H)
,5.10(tq,1H,J=7.1,1.2Hz,C
(8)H)。
MSm/e:198(M+ ),180,167,14
9,109,95,82,69(100%)。
高分解MSm/e:
理論値 C12H22O2 (M+ ):198
.1620。
実測値
:198.1622。[α]D 29: -30.67° (c=1
.. 02, CHCl3). IRνmax (film) cm −1 :3430(O
H), 1460, 1450, 1380, 900. 1H-NMR (CDCl3) δ: 0.96 (d
,3H,J=6.3Hz,C(5)H3),0.90
-2.13 (can be replaced with m, 8H, 1H D2O)
,1.61(s,3H,C(9)CH3),1.68
(d,3H,J=1.2Hz,C(9)CH3),2
.. 75-3.12(m, 2H, C(2)H and C(3)
H), 3.63 (ddd, 1H, J = 12.6, 7.1
, 3.9Hz, C(1)H), 3.94(ddd, 1H
, J=12.6, 6.0, 2.5, Hz, C(1)H)
,5.10(tq,1H,J=7.1,1.2Hz,C
(8)H). MSm/e: 198 (M+), 180, 167, 14
9,109,95,82,69 (100%). High resolution MSm/e: Theoretical value C12H22O2 (M+): 198
.. 1620. Actual value
:198.1622.
【0100】実施例4:(2R,3S,5R)−1−ク
ロロ−2,3−エポキシ−5,9−ジメチル−8−デセ
ンの調製Example 4: Preparation of (2R,3S,5R)-1-chloro-2,3-epoxy-5,9-dimethyl-8-decene
【0101】[0101]
【数4】[Math 4]
【0102】A法:エポキシアルコール体(4)(1.
398g,7.05ミリモル)の四塩化炭素(20ml
)溶液にトリフェニルホスフィン(2.774g,10
.58ミリモル)を加え、4.5時間加熱還流した。冷
却後、セライトろ過し、減圧下で溶媒を留去した。残留
物をカラムクロマトグラフィー(シリカゲル75g)で
処理し、ジエチルエーテル/n−ヘキサン〔1:100
(v/v)〕溶出部より無色油状のクロロエポキシド体
(5)(658mg,43%)を得た。理化学的データ
は以下の通りである。Method A: Epoxy alcohol (4) (1.
398 g, 7.05 mmol) of carbon tetrachloride (20 ml
) solution was triphenylphosphine (2.774 g, 10
.. 58 mmol) was added thereto, and the mixture was heated under reflux for 4.5 hours. After cooling, the mixture was filtered through Celite, and the solvent was distilled off under reduced pressure. The residue was treated with column chromatography (75 g of silica gel) and diluted with diethyl ether/n-hexane [1:100
(v/v)] A colorless oily chloroepoxide compound (5) (658 mg, 43%) was obtained from the eluate. The physical and chemical data are as follows.
【0103】〔α〕D 29:−13.34゜(c=1
.04,CHCl3 )。
IRνmax(film)cm −1 :1450,1
380,1260,930,900,740。
1H−NMR(CDCl3 )δ:0.98(d,3
H,J=6.4Hz,C(5)H3 ),1.14−2
.10(m,7H),1.60(s,3H,C(9)C
H3 ),1.68(d,3H,J=1.2Hz,C(
9)CH3 ),2.77−3.02(m,2H,C(
2)H及びC(3)H),3.35−3.78(m,2
H,C(1)H2 ),5.09(tt,1H,J=7
.1,1.2Hz,C(8)H)。
MSm/e:216(M+ ),200,198,18
3,163,149,109,95,81,69(10
0%)。
高分解MSm/e:
理論値 C12H21O35Cl(M+ ):2
16.1281。
実測値
:216.1254。[α]D 29:-13.34° (c=1
.. 04, CHCl3). IRνmax (film) cm −1 :1450,1
380, 1260, 930, 900, 740. 1H-NMR (CDCl3) δ: 0.98 (d, 3
H, J=6.4Hz, C(5)H3), 1.14-2
.. 10(m, 7H), 1.60(s, 3H, C(9)C
H3), 1.68(d, 3H, J=1.2Hz, C(
9) CH3), 2.77-3.02(m, 2H, C(
2) H and C (3) H), 3.35-3.78 (m, 2
H,C(1)H2),5.09(tt,1H,J=7
.. 1,1.2Hz, C(8)H). MSm/e: 216 (M+), 200, 198, 18
3,163,149,109,95,81,69 (10
0%). High resolution MSm/e: Theoretical value C12H21O35Cl (M+): 2
16.1281. Actual value
:216.1254.
【0104】[0104]
【数5】[Math 5]
【0105】B法:エポキシアルコール体(4)(77
.5mg,3915ミリモル)のジクロロメタン(2.
0ml)溶液に氷冷下で攪拌下にてトリエチルアミン(
0.12ml,861ミリモル)、4,4−ジメチルア
ミノピリジン(5.3mg,43ミリモル)及びp−ト
ルエンスルホニルクロライド(95.0mg,498ミ
リモル)を順に加えた。5分後、室温まで昇温し、更に
3時間攪拌した。減圧下で溶媒を留去した後、残渣をジ
エチルエーテルに溶解し、5%HCl水溶液、飽和炭酸
水素ナトリウム水溶液及び飽和塩化ナトリウム水溶液の
順に洗浄し、硫酸マグネシウムで乾燥し、減圧下で溶媒
を留去した。残留物をカラムクロマトグラフィー(シリ
カゲル6.0g)で処理し、ジエチルエーテル/n−ヘ
キサン〔1:6(v/v)〕溶出部より無色油状のクロ
ロエポキシド体(5)(5.1mg,6%)及び無色油
状の(2R,3S,5R)−2,3−エポキシ−5,9
−ジメチル−1−トルエンスルホニル)オキシ−8−デ
セン(6)(115mg,83%)を得た。理化学的デ
ータは以下の通りである。Method B: Epoxy alcohol (4) (77
.. 5 mg, 3915 mmol) of dichloromethane (2.
Add triethylamine (0 ml) to the solution under ice cooling and stirring.
0.12 ml, 861 mmol), 4,4-dimethylaminopyridine (5.3 mg, 43 mmol) and p-toluenesulfonyl chloride (95.0 mg, 498 mmol) were added in sequence. After 5 minutes, the temperature was raised to room temperature, and the mixture was further stirred for 3 hours. After evaporating the solvent under reduced pressure, the residue was dissolved in diethyl ether, washed successively with a 5% aqueous HCl solution, a saturated aqueous sodium bicarbonate solution, and a saturated aqueous sodium chloride solution, dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. I left. The residue was treated with column chromatography (6.0 g of silica gel), and a colorless oily chloroepoxide (5) (5.1 mg, 6 %) and colorless oily (2R,3S,5R)-2,3-epoxy-5,9
-dimethyl-1-toluenesulfonyl)oxy-8-decene (6) (115 mg, 83%) was obtained. The physical and chemical data are as follows.
【0106】〔α〕D 31:−29.94゜(c=1
.13,CHCl3 )。
IRνmax(film)cm −1 :1600,1
450,1365,1190,1100,965,81
5,665。
1H−NMR(CDCl3 )δ:0.93(d,3
H,J=6.4Hz,C(5)CH3 ),1.06−
2.20(m,7H),1.59(s,3H,C(9)
CH3 ),1.68(s,3H,C(9)CH3 )
,2.45(s,3H,CH3 Ar),2.66−3
.02(m,2H,C(2)H及びC(3)H),3.
83−4.32(m,2H,C(1)H2 ),5.0
7(tt,1H,J=7.1,1.2Hz,C(8)H
),7.35(d,3H,J=8.3Hz,芳香族性)
,7.80(d,3H,J=8.3Hz,芳香族性)。[α]D 31: -29.94° (c=1
.. 13, CHCl3). IRνmax (film) cm −1 :1600,1
450, 1365, 1190, 1100, 965, 81
5,665. 1H-NMR (CDCl3) δ: 0.93 (d, 3
H, J=6.4Hz, C(5)CH3), 1.06-
2.20 (m, 7H), 1.59 (s, 3H, C (9)
CH3), 1.68(s,3H,C(9)CH3)
,2.45(s,3H,CH3Ar),2.66-3
.. 02 (m, 2H, C(2)H and C(3)H), 3.
83-4.32 (m, 2H, C(1)H2), 5.0
7(tt, 1H, J=7.1, 1.2Hz, C(8)H
), 7.35 (d, 3H, J=8.3Hz, aromaticity)
, 7.80 (d, 3H, J=8.3Hz, aromaticity).
【0107】本例の化合物(6)を直ちに次の反応に用
いた。即ち、トシル体(6)(115mg,326ミリ
モル)のジメチルホルムアミド(2.0ml)溶液に塩
化リチウム(22.0mg,519ミリモル)を加え、
50℃で15分間攪拌した。冷却後、ジエチルエーテル
を用いて希釈し、飽和塩化ナトリウム水溶液で洗浄し、
硫酸マグネシウムで乾燥した後、減圧下で溶媒を留去し
た。残留物をカラムクロマトグラフィー(シリカゲル6
.0g)で処理し、ジエチルエーテル/n−ヘキサン〔
1:20(v/v)〕溶出部より無色油状のクロロエポ
キシド体(5)(64.2mg,91%)を得た。本化
合物の各種スペクトルデータは前記実施例4Aで調製し
た化合物のデータと一致した。Compound (6) of this example was immediately used in the next reaction. That is, lithium chloride (22.0 mg, 519 mmol) was added to a solution of tosyl compound (6) (115 mg, 326 mmol) in dimethylformamide (2.0 ml),
Stirred at 50°C for 15 minutes. After cooling, dilute with diethyl ether, wash with saturated aqueous sodium chloride solution,
After drying with magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was purified by column chromatography (silica gel 6
.. 0g) and diethyl ether/n-hexane [
1:20 (v/v)] A colorless oily chloroepoxide (5) (64.2 mg, 91%) was obtained from the eluate. Various spectral data of this compound were consistent with the data of the compound prepared in Example 4A above.
【0108】実施例5:(3S,5R)−5,9−ジメ
チル−8−デセン−1−イン−3−オールの調製Example 5: Preparation of (3S,5R)-5,9-dimethyl-8-decen-1-yn-3-ol
【01
09】01
09]
【数6】[Math 6]
【0110】n−ブチルリチウム(1.40Mヘキサン
溶液;14.0ml,19.6ミリモル)のテトラヒド
ロフラン(15ml)溶液に−25℃で攪拌下にエポキ
シクロライド体(5)(880mg,4.06ミリモル
)のテトラヒドロフラン(15ml)溶液を5分間かけ
て滴下した。10分後、飽和塩化アンモニウム水溶液を
加え、室温まで昇温した。ジエチルエーテルを用いて希
釈した後、飽和塩化ナトリウム水溶液で洗浄し、硫酸マ
グネシウムで乾燥した後、減圧下で溶媒を留去した。残
留物をカラムクロマトグラフィー(シリカゲル60g)
で処理し、ジエチルエーテル/n−ヘキサン〔1:9(
v/v)〕溶出部より無色油状のアセチレン体(7)(
730mg,100%)を得た。α−トリフロロメチル
−α−メトキシフェニル酢酸エステルの 1H−NMR
スペクトルの解析により、メチル基のキラリティーに関
しては74%e.e.で、また水酸基のキラリティーに
関しては93%e.e.であることを確認した。理化学
的データは以下の通りである。Epoxy chloride compound (5) (880 mg, 4.06 mmol) was added to a solution of n-butyllithium (1.40M hexane solution; 14.0 ml, 19.6 mmol) in tetrahydrofuran (15 ml) at -25°C with stirring. ) in tetrahydrofuran (15 ml) was added dropwise over 5 minutes. After 10 minutes, a saturated aqueous ammonium chloride solution was added, and the temperature was raised to room temperature. After diluting with diethyl ether, washing with saturated aqueous sodium chloride solution and drying over magnesium sulfate, the solvent was distilled off under reduced pressure. Column chromatography of the residue (60 g of silica gel)
diethyl ether/n-hexane [1:9 (
v/v)] A colorless oily acetylene body (7) (
730 mg, 100%) was obtained. 1H-NMR of α-trifluoromethyl-α-methoxyphenylacetic acid ester
Analysis of the spectrum revealed that the chirality of the methyl group was 74%e. e. And, regarding the chirality of the hydroxyl group, it is 93% e. e. It was confirmed that The physical and chemical data are as follows.
【0111】〔α〕D 30:−13.71゜(c=0
.70,CHCl3 )。
IRνmax(film)cm −1 :3390(O
H),3320,1450,1380,1060,10
20。
1H−NMR(CDCl3 )δ:0.97(d,3
H,J=5.9Hz,C(5)CH3 ),0.95−
2.20(m,8H,1H,D2 Oで交換可能),1
.61(br.s,3H,C(9)CH3 )1.69
(d,3H,J=1.2Hz,C(9)H3 ),2.
47(d,1H,J=2.0Hz,C(1)H),4.
23−4.60(m,1H,C(3)H),5.10(
tt,1H,J=7.1,1.2Hz,C(8)H)。
MSm/e:181(M+ +1),180(M+ )
,179,165,147,123,119,109,
95,69(100%)。
高分解MSm/e:
理論値 C12H20O(M+ ):180.1
515。
実測値
:180.1505。
元素分析理論値:C12H20O:C=70.94;H
=11.18実測値 :C=70.72
;H=11.14。[α]D 30: -13.71° (c=0
.. 70, CHCl3). IRνmax (film) cm −1 :3390(O
H), 3320, 1450, 1380, 1060, 10
20. 1H-NMR (CDCl3) δ: 0.97 (d, 3
H, J=5.9Hz, C(5)CH3), 0.95-
2.20 (can be replaced with m, 8H, 1H, D2O), 1
.. 61 (br.s, 3H, C(9)CH3) 1.69
(d, 3H, J=1.2Hz, C(9)H3), 2.
47 (d, 1H, J=2.0Hz, C(1)H), 4.
23-4.60(m, 1H, C(3)H), 5.10(
tt, 1H, J=7.1, 1.2Hz, C(8)H). MSm/e: 181 (M+ +1), 180 (M+)
,179,165,147,123,119,109,
95,69 (100%). High resolution MSm/e: Theoretical value C12H20O(M+): 180.1
515. Actual value
:180.1505. Elemental analysis theoretical value: C12H20O:C=70.94;H
=11.18 Actual value: C=70.72
;H=11.14.
【0112】実施例6:(3S,5R)−3−(t−ブ
チルジメチルシリル)オキシ−5,9−ジメチル−8−
デセン−1−イン−の調製Example 6: (3S,5R)-3-(t-butyldimethylsilyl)oxy-5,9-dimethyl-8-
Preparation of decen-1-yne-
【0113】[0113]
【数7】[Math 7]
【0114】アルコール体(7)(252mg,1.4
0ミリモル)のジクロロメタン(4.0ml)溶液に氷
冷下で攪拌下にてトリエチルアミン(0.39ml,2
.80ミリモル)、4,4−ジメチルアミノピリジン(
17.0mg,0.14モル)及びt−ブチルジメチル
ブチルクロリド(253mg,1.68ミリモル)を順
に加えた。
5分後、室温まで昇温し、更に21.5時間攪拌した。
減圧下で溶媒を留去した後、残渣をジエチルエーテルに
溶解し、飽和塩化ナトリウム水溶液で洗浄し、硫酸マグ
ネシウムで乾燥した後、減圧下で溶媒を留去した。残留
物をカラムクロマトグラフィー(シリカゲル24g)で
処理し、ジエチルエーテル−n−ヘキサン〔1:6(v
/v)〕溶出部より無色油状のシリルエーテル体(8)
(397mg,96%)を得た。理化学的データは以下
の通りである。Alcohol compound (7) (252 mg, 1.4
To a solution of 0 mmol) in dichloromethane (4.0 ml) was added triethylamine (0.39 ml, 2
.. 80 mmol), 4,4-dimethylaminopyridine (
17.0 mg, 0.14 mol) and t-butyldimethylbutyl chloride (253 mg, 1.68 mmol) were added in sequence. After 5 minutes, the temperature was raised to room temperature, and the mixture was further stirred for 21.5 hours. After evaporating the solvent under reduced pressure, the residue was dissolved in diethyl ether, washed with a saturated aqueous sodium chloride solution, and dried over magnesium sulfate, and then the solvent was evaporated under reduced pressure. The residue was treated with column chromatography (24 g of silica gel) and diluted with diethyl ether-n-hexane [1:6 (v
/v)] Colorless oily silyl ether compound (8) from the eluted part
(397 mg, 96%) was obtained. The physical and chemical data are as follows.
【0115】〔α〕D 31:−46.95゜(c=1
.04,CHCl3 )。
IRνmax(film)cm −1 :3300,1
460,1380,1360,1250,1090,1
000,935,900,830,775。
1H−NMR(CDCl3 )δ:0.11(d,3
H,CH3 Si),0.14(s,3H,CH3 S
i),0.90(d,3H,J=5.9Hz,C(5)
CH3 )0.90(s,9H,(CH3 )CSi)
,1.00−2.17(m,7H),1.60(br.
s.3H,C(9)CH3 ),1.68(br.s,
3H,C(9)H3 ),2.37(d,1H,J=2
.2Hz,C(1)H),4.26−4.53(m,1
H,C(3)H),4.90−5.22(m,1H,C
(8)H)。
MSm/e:295(M+ +1),294(M+ )
,279,269,237,193,147,109,
95,75(100%),69。
高分解MSm/e:
理論値 C18H34OSi(M+ ):294
.2379。
実測値
:294.2381。
元素分析理論値:C18H34OSi:C=73.40
;H=11.63実測値
:C=72.99;H=11.5
0。[α]D 31: -46.95° (c=1
.. 04, CHCl3). IRνmax (film) cm −1 :3300,1
460, 1380, 1360, 1250, 1090, 1
000,935,900,830,775. 1H-NMR (CDCl3) δ: 0.11 (d, 3
H, CH3 Si), 0.14(s, 3H, CH3 S
i), 0.90(d, 3H, J=5.9Hz, C(5)
CH3)0.90(s,9H,(CH3)CSi)
, 1.00-2.17 (m, 7H), 1.60 (br.
s. 3H, C(9)CH3), 1.68(br.s,
3H, C(9)H3), 2.37(d, 1H, J=2
.. 2Hz, C(1)H), 4.26-4.53(m, 1
H, C (3) H), 4.90-5.22 (m, 1H, C
(8)H). MSm/e: 295 (M+ +1), 294 (M+)
,279,269,237,193,147,109,
95,75(100%),69. High resolution MSm/e: Theoretical value C18H34OSi (M+): 294
.. 2379. Actual value
:294.2381. Elemental analysis theoretical value: C18H34OSi: C=73.40
;H=11.63 actual value
:C=72.99;H=11.5
0.
【0116】実施例7:(4S,6R)−4−(t−ブ
チルジメチルシリル)オキシ−6,10−ジメチル−9
−ウンデセン−2−インの調製Example 7: (4S,6R)-4-(t-butyldimethylsilyl)oxy-6,10-dimethyl-9
-Preparation of undecen-2-yne
【0117】[0117]
【数8】[Math. 8]
【0118】シリルエーテル体(8)(708mg,2
.40ミリモル)のテトラヒドロフラン(15ml)/
ヘキサメチルホスホリックトリアミド(0.8ml)混
合溶液に、−42℃で攪拌下にn−ブチルリチウム(1
.40Mヘキサン溶液;2.70ml,3.78ミリモ
ル)を加えた。20分後、ヨードメタン(0.24ml
,3.86ミリモル)を滴下した後、−5℃まで昇温し
、更に10時間攪拌した。飽和塩化アンモニウム水溶液
を加えた後、室温まで昇温し、ジエチルエーテルを用い
て希釈し、飽和塩化ナトリウム水溶液で洗浄し、硫酸マ
グネシウムで乾燥した後、減圧下で溶媒を留去した。残
留物をカラムクロマトグラフィー(シリカゲル40g)
で処理し、n−ヘキサン溶出部より無色油状のシリルエ
ーテル体(9)(702mg,95%)を得た。理化学
的データは以下の通りである。Silyl ether compound (8) (708 mg, 2
.. 40 mmol) of tetrahydrofuran (15 ml)/
To a mixed solution of hexamethylphosphoric triamide (0.8 ml) was added n-butyllithium (1
.. 40M hexane solution; 2.70 ml, 3.78 mmol) was added. After 20 minutes, iodomethane (0.24 ml
, 3.86 mmol) was added dropwise, the temperature was raised to -5°C, and the mixture was further stirred for 10 hours. After adding a saturated aqueous ammonium chloride solution, the mixture was heated to room temperature, diluted with diethyl ether, washed with a saturated aqueous sodium chloride solution, dried over magnesium sulfate, and then the solvent was distilled off under reduced pressure. Column chromatography of the residue (40 g of silica gel)
A colorless oily silyl ether (9) (702 mg, 95%) was obtained from the n-hexane eluate. The physical and chemical data are as follows.
【0119】〔α〕D 31:−50.63゜(c=1
.03,CHCl3 )。
IRνmax(film)cm −1 :1460,1
375,1360,1250,1090,980,90
0,835,775。
1H−NMR(CDCl3 )δ:0.10(s,3
H,CH3 Si),0.12(s,3H,CH3 S
i),0.90(d,3H,J=5.8Hz,C(6)
CH3 ),0.90(s,9H,(CH3 )3 C
Si),0.98−2.17(m,7H),1.60(
br.s,3H,C(10)CH3 ),1.67(d
,3H,J=1.0Hz,C(10)CH3 ),1.
81(d,3H,J=2.2Hz,C(1)H3 ),
4.22−4.50(m,1H,C(4)H),4.9
5−5.22(m,1H,C(9)H)。
MSm/e:308(M+ ),293,265,25
1,223,211,183,161,137,97,
75(100%),69。
高分解MSm/e:
理論値 C19H36OSi(M+ ):308
.2536。
実測値
:308.2504。
元素分析理論値:C19H36OSi:C=73.95
;H=11.76実測値
:C=73.86;H=11.6
6。[α]D 31: -50.63° (c=1
.. 03, CHCl3). IRνmax (film) cm −1 :1460,1
375, 1360, 1250, 1090, 980, 90
0,835,775. 1H-NMR (CDCl3) δ: 0.10 (s, 3
H, CH3 Si), 0.12 (s, 3H, CH3 S
i), 0.90(d, 3H, J=5.8Hz, C(6)
CH3),0.90(s,9H,(CH3)3C
Si), 0.98-2.17 (m, 7H), 1.60 (
br. s,3H,C(10)CH3),1.67(d
, 3H, J=1.0Hz, C(10)CH3), 1.
81 (d, 3H, J=2.2Hz, C(1)H3),
4.22-4.50 (m, 1H, C(4)H), 4.9
5-5.22 (m, 1H, C(9)H). MSm/e: 308 (M+), 293, 265, 25
1,223,211,183,161,137,97,
75 (100%), 69. High resolution MSm/e: Theoretical value C19H36OSi (M+): 308
.. 2536. Actual value
:308.2504. Elemental analysis theoretical value: C19H36OSi: C=73.95
;H=11.76 actual value
:C=73.86;H=11.6
6.
【0120】実施例8:(4S,6R)−6,10−ジ
メチル−9−ウンデセン−2−イン−4−オールの調製
Example 8: Preparation of (4S,6R)-6,10-dimethyl-9-undecen-2-yn-4-ol
【0121】[0121]
【数9】[Math. 9]
【0122】シリルエーテル体(9)(685mg,2
.22ミリモル)のテトラヒドロフラン(10ml)溶
液に室温下で攪拌下にてテトラn−ブチルアンモニウム
クロリド(1.0Mテトラヒドロフラン溶液;0.70
ml,0.70モル)を加えた。50分後、ジエチルエ
ーテルを用いて希釈し、飽和塩化ナトリウム水溶液で洗
浄し、硫酸マグネシウムで乾燥した後、減圧下で溶媒を
留去した。残留物をカラムクロマトグラフィー(シリカ
ゲル24g)で処理し、ジエチルエーテル/n−ヘキサ
ン〔1:4(v/v)〕溶出部より無色油状のアセチレ
ンアルコール体(10)(432mg,100%)を得
た。
理化学的データは以下の通りである。Silyl ether (9) (685 mg, 2
.. Tetra n-butylammonium chloride (1.0M solution in tetrahydrofuran; 0.70
ml, 0.70 mol) was added. After 50 minutes, the mixture was diluted with diethyl ether, washed with saturated aqueous sodium chloride solution, dried over magnesium sulfate, and then the solvent was distilled off under reduced pressure. The residue was treated with column chromatography (24 g of silica gel) to obtain acetylene alcohol compound (10) (432 mg, 100%) as a colorless oil from the diethyl ether/n-hexane [1:4 (v/v)] eluate. Ta. The physical and chemical data are as follows.
【0123】〔α〕D 27:−10.32゜(c=1
.04,CHCl3 )。
IRνmax(film)cm −1 :3380(O
H),1450,1380,1140,1050。
1H−NMR(CDCl3 )δ:0.93(d,3
H,J=6.4Hz,C(6)CH3 ),0.96−
2.22(m,8H,1H,D2 Oで交換可能),1
.60(br.s,3H,C(10)CH3 ),1.
69(br.s,3H,C(10)CH3 )1.84
(d,3H,J=2.2Hz,C(1)H3 ),4.
21−4.58(m,1H,C(4)H),4.96−
5.24(m,1H,C(9)H)。
MSm/e:194(M+ ),179,161,11
9,109,95,69,(100%)。
高分解MSm/e:
理論値 C13H22O(M+ ):194.1
671。
実測値
:194.1675。[α]D 27: -10.32° (c=1
.. 04, CHCl3). IRνmax (film) cm −1 :3380(O
H), 1450, 1380, 1140, 1050. 1H-NMR (CDCl3) δ: 0.93 (d, 3
H, J=6.4Hz, C(6)CH3), 0.96-
2.22 (can be replaced with m, 8H, 1H, D2O), 1
.. 60 (br.s, 3H, C(10)CH3), 1.
69 (br.s, 3H, C(10)CH3) 1.84
(d, 3H, J=2.2Hz, C(1)H3), 4.
21-4.58 (m, 1H, C(4)H), 4.96-
5.24 (m, 1H, C(9)H). MSm/e: 194 (M+), 179, 161, 11
9,109,95,69,(100%). High resolution MSm/e: Theoretical value C13H22O(M+): 194.1
671. Actual value
:194.1675.
【0124】実施例9:(4S,6R)−(Z)−6,
10−ジメチル−2,9−ウンデカジエン−4−オール
及び(4S,6R)−(E)−6,10−ジメチル−2
,9−ウンデカジエン−4−オールの調製Example 9: (4S,6R)-(Z)-6,
10-dimethyl-2,9-undecadien-4-ol and (4S,6R)-(E)-6,10-dimethyl-2
, 9-Undecadien-4-ol preparation
【0125】[0125]
【数10】[Math. 10]
【0126】アセチレン体(10)(432mg,2.
22ミリモル)のテトラヒドロフラン(10ml)溶液
に氷冷下で攪拌下にて水素化アルミニウムリチウム(1
02mg,2.68ミリモル)を加えた。8時間加熱還
流した後、再び氷冷し、飽和水酸化アンモニウム水溶液
を滴下し、過剰の試薬及び複合体を分解した。セライト
及びジクロロメタンを加え、室温下で更に12時間攪拌
した。
セライトろ過後、硫酸マグネシウムで乾燥し、減圧下で
溶媒を留去した。残留物をカラムクロマトグラフィー(
シリカゲル25g)で処理し、ジエチルエーテル/n−
ヘキサン〔1:20(v/v)〕溶出部より無色油状の
(E)−アリルアルコール体(12)(322mg,7
4%)及び(Z)−アリルアルコール体(11)(61
mg,14%)を得た。理化学的データは以下の通りで
ある。Acetylene compound (10) (432 mg, 2.
Lithium aluminum hydride (22 mmol) was added to a solution of lithium aluminum hydride (10 ml) in tetrahydrofuran (10 ml) under stirring under ice cooling.
02 mg, 2.68 mmol) was added. After heating under reflux for 8 hours, the mixture was cooled on ice again, and a saturated aqueous ammonium hydroxide solution was added dropwise to decompose the excess reagent and complex. Celite and dichloromethane were added, and the mixture was further stirred at room temperature for 12 hours. After filtering through Celite, it was dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to column chromatography (
25 g of silica gel) and diethyl ether/n-
The hexane [1:20 (v/v)] eluate was obtained as a colorless oil (E)-allyl alcohol compound (12) (322 mg, 7
4%) and (Z)-allylic alcohol (11) (61
mg, 14%) was obtained. The physical and chemical data are as follows.
【0127】(E)−アリルアルコール体(12)〔α
〕D 29:−10.25゜(c=1.01,CHCl
3 )。
IRνmax(film)cm −1 :3350(O
H),1450,1380,965。
1H−NMR(CDCl3 )δ:0.92(d,3
H,J=6.1Hz,C(6)CH3 ),0.90−
2.17(m,7H),1.33(d,1H,J=4.
2Hz,D2 Oで交換可能,OH),1.60(br
.s,3H,C(10)CH3 ),1.66(br.
s,3H,C(10)CH3 ),1.70(d,3H
,J=3.2Hz,C(1)H3 ),3.96−4.
30(m,1H,C(4)H),4.93−5.26(
m,1H,C(9)H),5.26−5.92(m,2
H,C(2)H及びC(3)H)。
MSm/e:196(M+ ),178,163,14
9,71(100%),69。
高分解MSm/e:
理論値 C13H24O(M+ ):196.1
828。
実測値
:196.1848。(E)-Allyl alcohol (12) [α
] D 29: -10.25° (c=1.01, CHCl
3). IRνmax (film) cm −1 :3350(O
H), 1450, 1380, 965. 1H-NMR (CDCl3) δ: 0.92 (d, 3
H, J=6.1Hz, C(6)CH3), 0.90-
2.17 (m, 7H), 1.33 (d, 1H, J=4.
2Hz, exchangeable with D2 O, OH), 1.60 (br
.. s,3H,C(10)CH3), 1.66(br.
s,3H,C(10)CH3),1.70(d,3H
, J=3.2Hz, C(1)H3), 3.96-4.
30(m, 1H, C(4)H), 4.93-5.26(
m, 1H, C(9)H), 5.26-5.92 (m, 2
H, C(2)H and C(3)H). MSm/e: 196 (M+), 178, 163, 14
9,71(100%),69. High resolution MSm/e: Theoretical value C13H24O(M+): 196.1
828. Actual value
:196.1848.
【0128】(Z)−アリルアルコール体(11)〔α
〕D 30:−8.01゜(c=0.78,CHCl3
)。
IRνmax(film)cm −1 :3350(O
H),1445,1380,960。
1H−NMR(CDCl3 )δ:0.90(d,3
H,J=5.6Hz,C(6)CH3 ),0.90−
2.16(m,7H),1.38(d,1H,J=3.
4Hz,D2 Oで交換可能,OH),1.60(br
.s,3H,C(10)CH3 ),1.67(br.
s,3H,C(10)CH3 ),1.70(d,3H
,J=3.4Hz,C(1)H3 ),3.92−4.
32(m,1H,C(4)H),4.94−5.26(
m,1H,C(9)H),5.26−5.88(m,2
H,C(2)H及びC(3)H)(Z)-Allyl alcohol (11) [α
] D 30: -8.01° (c=0.78, CHCl3
). IRνmax (film) cm −1 :3350(O
H), 1445, 1380, 960. 1H-NMR (CDCl3) δ: 0.90 (d, 3
H, J=5.6Hz, C(6)CH3), 0.90-
2.16 (m, 7H), 1.38 (d, 1H, J=3.
4Hz, replaceable with D2 O, OH), 1.60 (br
.. s,3H,C(10)CH3), 1.67(br.
s,3H,C(10)CH3),1.70(d,3H
, J=3.4Hz, C(1)H3), 3.92-4.
32(m, 1H, C(4)H), 4.94-5.26(
m, 1H, C(9)H), 5.26-5.88 (m, 2
H, C(2)H and C(3)H)
【0129】実施例10:エチル(3S,7R)−(E
)−3,7,11−トリメチル−4,10−ドデカジエ
ノエートの調製Example 10: Ethyl (3S,7R)-(E
)-3,7,11-trimethyl-4,10-dodecadienoate preparation
【0130】[0130]
【数11】[Math. 11]
【0131】(E)−アリルアルコール体(12)(2
80mg,1.43モル),ピバル酸(10.0mg,
0.27ミリモル),トリエチルオルトアセテート(4
.0ml,21.8ミリモル)の混合物を160℃でデ
ィーン・スターク装置をつけて2時間加熱した。冷却後
、ジエチルエーテルを用いて希釈し、飽和炭酸水素ナト
リウム水溶液、飽和塩化ナトリウム水溶液の順で洗浄し
、硫酸マグネシウムで乾燥した後、減圧下で溶媒を留去
した。
残留物をカラムクロマトグラフィー(シリカゲル12g
)で処理し、ジエチルエーテル/n−ヘキサン〔1:1
00(v/v)〕溶出部より無色油状のエステル体(1
3)(335mg,93%)を得た。理化学的データは
以下の通りである。(E)-Allyl alcohol (12) (2
80 mg, 1.43 mol), pivalic acid (10.0 mg,
0.27 mmol), triethyl orthoacetate (4
.. 0 ml, 21.8 mmol) was heated at 160° C. for 2 hours on a Dean-Stark apparatus. After cooling, it was diluted with diethyl ether, washed successively with a saturated aqueous sodium hydrogen carbonate solution and a saturated aqueous sodium chloride solution, dried over magnesium sulfate, and then the solvent was distilled off under reduced pressure. The residue was purified by column chromatography (12 g of silica gel).
) and diethyl ether/n-hexane [1:1
00 (v/v)] Colorless oily ester (1
3) (335 mg, 93%) was obtained. The physical and chemical data are as follows.
【0132】〔α〕D 29:+14.51゜(c=1
.11,CHCl3 )。
IRνmax(film)cm −1 :1735(C
=O),1450,1375,970。
1H−NMR(CDCl3 )δ:0.84(d,3
H,J=6.1Hz,C(7)CH3 ),1.03(
d,3H,J=6.6Hz,C(3)CH3 ),0.
60−2.50(m,9H),1.24(t,3H,J
=7.1Hz,OCH2 CH3 ),1.59(br
.s,3H,C(11)CH3 ),1.68(d,3
H,J=1.0Hz,C(11)CH3 ),2.25
−2.88(m,1H,C(3)H),4.11(q,
2H,J=7.1Hz,OCH2 CH3 ),4.9
2−5.30(m,1H,C(10)H),5.05−
5.66(m,2H,C(4)H及びC(5)H)。
13C−NMR(CDCl3 )δ:14.26(q)
,17.56(q),19.30(q),20.49(
q),25.58(q),25.58(t),32.7
3(d),33.76(d),36.58(t),39
.83(t),42.00(t),59.93(t),
124.94(d),127.86(d),130.8
4(s),135.45(d),172.39(s)。
MSm/e:267(M+ +1),266(M+ )
,251,223,178,135,123,109,
95,82,69(100%)。
高分解MSm/e:
理論値 C17H30O2 (M+ ):266
.2246。
実測値
:266.2229。[α]D 29: +14.51° (c=1
.. 11, CHCl3). IRνmax (film) cm −1 : 1735 (C
=O), 1450, 1375, 970. 1H-NMR (CDCl3) δ: 0.84 (d, 3
H, J=6.1Hz, C(7)CH3), 1.03(
d, 3H, J=6.6Hz, C(3)CH3), 0.
60-2.50 (m, 9H), 1.24 (t, 3H, J
=7.1Hz, OCH2 CH3 ), 1.59(br
.. s,3H,C(11)CH3),1.68(d,3
H, J=1.0Hz, C(11)CH3), 2.25
-2.88 (m, 1H, C(3)H), 4.11 (q,
2H, J=7.1Hz, OCH2 CH3 ), 4.9
2-5.30 (m, 1H, C(10)H), 5.05-
5.66 (m, 2H, C(4)H and C(5)H). 13C-NMR (CDCl3) δ: 14.26 (q)
, 17.56 (q), 19.30 (q), 20.49 (
q), 25.58 (q), 25.58 (t), 32.7
3(d), 33.76(d), 36.58(t), 39
.. 83(t), 42.00(t), 59.93(t),
124.94(d), 127.86(d), 130.8
4(s), 135.45(d), 172.39(s). MSm/e: 267 (M+ +1), 266 (M+)
,251,223,178,135,123,109,
95, 82, 69 (100%). High resolution MSm/e: Theoretical value C17H30O2 (M+): 266
.. 2246. Actual value
:266.2229.
【0133】実施例11:エチル(3R,7R)−3,
7,11−トリメチルドデカノエートの調製Example 11: Ethyl (3R,7R)-3,
Preparation of 7,11-trimethyldodecanoate
【0134
】0134
]
【数12】[Math. 12]
【0135】エステル体(13)(346mg,1.3
0ミリモル)のエチルアルコール(5.0ml)溶液に
10%パラジウム−炭素(17.2mg)を加え、水素
気流下にて室温で2.5時間攪拌した。セライトろ過し
た後、減圧下で溶媒を留去した。得られた残留物をカラ
ムクロマトグラフィー(シリカゲル8.0g)で処理し
、ジエチルエーテル/n−ヘキサン〔1:50(v/v
)〕溶出部より無色油状のエステル体(14)(338
mg,96%)を得た。理化学的データは以下の通りで
ある。[0135] Ester (13) (346 mg, 1.3
0 mmol) in ethyl alcohol (5.0 ml) was added 10% palladium-carbon (17.2 mg), and the mixture was stirred at room temperature for 2.5 hours under a hydrogen stream. After filtering through Celite, the solvent was distilled off under reduced pressure. The resulting residue was treated with column chromatography (8.0 g of silica gel) and treated with diethyl ether/n-hexane [1:50 (v/v
)] Colorless oily ester (14) (338
mg, 96%) was obtained. The physical and chemical data are as follows.
【0136】〔α〕D 27:+2.34゜(c=1.
02,n−オクタン)〔文献値:〔α〕D :+2.2
4(c=4.99,n−オクタン)〕。
IRνmax(film)cm −1 :1735(C
=O),1460,1370,1245,1170,1
030。
1H−NMR(CDCl3 )δ:0.68−1.7
3(m,26H),1.26(t,3H,J=7.1H
z,OCH2 CH3 ),1.73 −2.43(
m,3H,C(2)CH2 及びC(3)H),4.1
3(q,2H,J=7.1Hz,OCH2 CH3 )
。
13C−NMR(CDCl3 )δ:14.26(q)
,19.62(q),19.73(q),22.55(
q),22.66(q),23.23(t),24.7
7(t),27.96(d),30.35(d),32
.73(t),37.07(d),37.18(t),
37.19(t),39.40(t),41.83(t
),59.82(t),172.93(s)。
MSm/e:271(M+ +1),270(M+ )
,255,227,185,157,115,97,8
8(100%),83,69。
高分解MSm/e:
理論値 C17H34O2 (M+ ):270
.2559。
実測値 270.2552。[α]D 27: +2.34° (c=1.
02,n-octane) [Literature value: [α]D: +2.2
4 (c=4.99, n-octane)]. IRνmax (film) cm −1 : 1735 (C
=O), 1460, 1370, 1245, 1170, 1
030. 1H-NMR (CDCl3) δ: 0.68-1.7
3 (m, 26H), 1.26 (t, 3H, J = 7.1H
z, OCH2 CH3 ), 1.73 -2.43(
m, 3H, C(2)CH2 and C(3)H), 4.1
3 (q, 2H, J=7.1Hz, OCH2 CH3)
. 13C-NMR (CDCl3) δ: 14.26 (q)
, 19.62 (q), 19.73 (q), 22.55 (
q), 22.66 (q), 23.23 (t), 24.7
7(t), 27.96(d), 30.35(d), 32
.. 73(t), 37.07(d), 37.18(t),
37.19 (t), 39.40 (t), 41.83 (t
), 59.82 (t), 172.93 (s). MSm/e: 271 (M+ +1), 270 (M+)
,255,227,185,157,115,97,8
8 (100%), 83, 69. High resolution MSm/e: Theoretical value C17H34O2 (M+): 270
.. 2559. Actual value 270.2552.
【0137】実施例12:(3R,7R)−3,7,1
1−トリメチルドデカン−1−オールの調製Example 12: (3R,7R)-3,7,1
Preparation of 1-trimethyldodecane-1-ol
【0138
】0138
]
【数13】[Math. 13]
【0139】エステル体(14)(121mg,447
ミリモル)のテトラヒドロフラン(4.0ml)溶液に
氷冷下にて攪拌下で水素化アルミニウムリチウム(18
.0mg,474ミリモル)を加えた。50分後、飽和
水酸化アンモニウム水溶液を滴下し、過剰の試薬及び複
合体を分解した。セライト及びジクロロメタンを加え、
室温下で更に10時間攪拌した。セライトろ過後、硫酸
マグネシウムで乾燥し、減圧下で溶媒を留去した。残留
物をカラムクロマトグラフィー(シリカゲル6.0g)
で処理し、ジエチルエーテル/n−ヘキサン〔1:6(
v/v)〕溶出部より無色油状のアルコール体(15)
(102mg,100%)を得た。理化学的データは以
下の通りである。[0139] Ester (14) (121 mg, 447
Lithium aluminum hydride (18 mmol) was added to a solution of lithium aluminum hydride (18
.. 0 mg, 474 mmol) was added. After 50 minutes, a saturated aqueous ammonium hydroxide solution was added dropwise to decompose excess reagent and complex. Add celite and dichloromethane,
The mixture was further stirred at room temperature for 10 hours. After filtering through Celite, it was dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. Column chromatography of the residue (6.0 g of silica gel)
diethyl ether/n-hexane [1:6 (
v/v)] Colorless oily alcohol from the eluted part (15)
(102 mg, 100%) was obtained. The physical and chemical data are as follows.
【0140】〔α〕D 27:+2.93゜(c=1.
02,CHCl3 )〔文献値:〔α〕D 18:+3
.49゜(c=0.98,CHCl3 )〕。
IRνmax(film)cm −1 :3330(O
H),1460,1380,1370,1055。
1H−NMR(CDCl3 )δ:0.45−1.8
0(m,30H,1H,D2 Oで交換可能),3.6
9(br.t,2H,J=6.6Hz,C(1)H2
OH)。
MSm/e:210(M+ −H2 O),182,1
40,125,111,97,83,69,57(10
0%)。
高分解MSm/e:
理論値 C15H30(M+ −H2 O):2
10.2348。
実測値 210.2310。[α]D 27: +2.93° (c=1.
02, CHCl3 ) [Literature value: [α]D 18:+3
.. 49° (c=0.98, CHCl3)]. IRνmax (film) cm −1 :3330(O
H), 1460, 1380, 1370, 1055. 1H-NMR (CDCl3) δ: 0.45-1.8
0 (m, 30H, 1H, exchangeable with D2 O), 3.6
9(br.t, 2H, J=6.6Hz, C(1)H2
OH). MSm/e:210(M+-H2O),182,1
40, 125, 111, 97, 83, 69, 57 (10
0%). High resolution MSm/e: Theoretical value C15H30(M+ -H2O): 2
10.2348. Actual value 210.2310.
【0141】実施例13:(3R,7R)−1−ブルモ
−3,7,11−トリメチルドデカンの調製Example 13: Preparation of (3R,7R)-1-brumo-3,7,11-trimethyldodecane
【0142
】0142
]
【数14】[Math. 14]
【0143】アルコール体(15)(121mg,53
0ミリモル)のジクロロメタン(3.0ml)溶液に、
室温にて攪拌下で四臭化炭素(231mg,697ミリ
モル)及びトリフェニルホスフィン(183mg,69
8ミリモル)を加えた。110分後に減圧下で溶媒を留
去し、残渣をジエチルエーテルに溶解した後、飽和塩化
ナトリウム水溶液で洗浄し、硫酸マグネシウムで乾燥し
、減圧下で溶媒を留去した。残留物をカラムクロマトグ
ラフィー(シリカゲル20g)によって処理し、n−ヘ
キサン溶出部より無色油状のブロモ体(16)(154
mg,100%)を得た。理化学的データは以下の通り
である。Alcohol compound (15) (121 mg, 53
0 mmol) in dichloromethane (3.0 ml),
Carbon tetrabromide (231 mg, 697 mmol) and triphenylphosphine (183 mg, 69 mmol) were dissolved under stirring at room temperature.
8 mmol) was added. After 110 minutes, the solvent was distilled off under reduced pressure, and the residue was dissolved in diethyl ether, washed with a saturated aqueous sodium chloride solution, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was treated with column chromatography (20 g of silica gel), and the bromo compound (16) (154
mg, 100%) was obtained. The physical and chemical data are as follows.
【0144】〔α〕D 29:−3.85゜(c=1.
04,CHCl3 )〔文献値:〔α〕D 24:−4
.44゜(c=5.0,CHCl3 )〕。
IRνmax(film)cm −1 :1460,1
380,1370。
1H−NMR(CDCl3 )δ:0.70−2.1
7(m,29H),3.28−3.60(m,2H,C
(1)H2 Br)。
MSm/e:292(M*+ ),290(M+ ),
277,275,249,247、165,163,1
51,149,113,97,71,83,69,57
(100%)。
高分解MSm/e:
理論値 C15H3181Br(M*+ ):2
92.1588実測値
:292.1612。
理論値 C15H3179Br(M+ ):29
0.1610実測値
:290.1649。[α]D 29: -3.85° (c=1.
04, CHCl3 ) [Literature value: [α]D 24:-4
.. 44° (c=5.0, CHCl3)]. IRνmax (film) cm −1 :1460,1
380,1370. 1H-NMR (CDCl3) δ: 0.70-2.1
7 (m, 29H), 3.28-3.60 (m, 2H, C
(1)H2Br). MSm/e: 292 (M*+), 290 (M+),
277,275,249,247,165,163,1
51,149,113,97,71,83,69,57
(100%). High resolution MSm/e: Theoretical value C15H3181Br (M**): 2
92.1588 actual measurement value
:292.1612. Theoretical value C15H3179Br (M+): 29
0.1610 actual measurement value
:290.1649.
【0145】実施例14:(6R,10R)−6,10
,14−トリメチルペンタデカン−2−オンの調製Example 14: (6R,10R)-6,10
, 14-trimethylpentadecane-2-one preparation
【0
146】0
146]
【数15】[Math. 15]
【0147】アセトンジメチルヒドラゾン(53.7m
g,536ミリモル)のテトラヒドロフラン(1.0m
l)溶液に−78℃で攪拌下にてn−ブチルリチウム(
1.40Mヘキサン溶液;380ml,532ミリモル
)を加えた。30分後にブロム体(16)(91.0m
g,312ミリモル)のテトラヒドロフラン(2.0m
l)溶液を滴下し、更に同温下で1時間攪拌した。反応
液を室温まで昇温し、更に130分間攪拌した。酢酸(
0.20ml)及びH2 O(1.0ml)を加え、更
に50分間攪拌した。ジエチルエーテルを用いて希釈し
、飽和炭酸水素ナトリウム水溶液及び飽和塩化ナトリウ
ム溶液で洗浄し、硫酸マグネシウムで乾燥した後、減圧
下で溶媒を留去した。残留物をカラムクロマトグラフィ
ー(シリカゲル6.0g)で処理し、ジエチルエーテル
/n−ヘキサン〔1:10(v/v)〕溶出部より無色
油状のケトン体(17)(67.mg,80%)を得た
。理化学的データは以下の通りである。Acetone dimethyl hydrazone (53.7 m
g, 536 mmol) of tetrahydrofuran (1.0 m
l) Add n-butyllithium (
A 1.40M hexane solution; 380 ml, 532 mmol) was added. After 30 minutes, bromine body (16) (91.0 m
g, 312 mmol) of tetrahydrofuran (2.0 m
l) The solution was added dropwise, and the mixture was further stirred at the same temperature for 1 hour. The reaction solution was heated to room temperature and further stirred for 130 minutes. Acetic acid (
0.20 ml) and H2O (1.0 ml) were added and stirred for an additional 50 minutes. After diluting with diethyl ether, washing with saturated aqueous sodium hydrogen carbonate solution and saturated sodium chloride solution, and drying over magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was treated with column chromatography (6.0 g of silica gel), and the diethyl ether/n-hexane [1:10 (v/v)] eluate yielded a colorless oily ketone (17) (67. mg, 80%). ) was obtained. The physical and chemical data are as follows.
【0148】〔α〕D 26:+1.03゜(c=1.
02,CHCl3 )。
IRνmax(film)cm −1 :1720(C
=O),1460,1375,1360。
1H−NMR(CDCl3 )δ:0.70−1.8
4(m,31H),2.13(s,3H,C(1)H3
),2.41(br.t,2H,J=7.3Hz,C
(3)H2 )。
13C−NMR(CDCl3 )δ:19.51(q)
,19.67(q),21.32(t),22.55(
q),22.64(q),24.35(t),24.7
3(t),27.89(d),29.67(q),32
.60(d),32.71(d),36.42(t),
37.17(t),37.22(t),37.34(t
),39.31(t),43.96(t),208.7
0(s)。
MSm/e:268(M+ 1),250,210,1
24,109,95,85,71,58(100%)。
高分解MSm/e:
理論値 C18H36O(M+ ):268.2
766。
実測値
:268.2742。[α]D 26:+1.03° (c=1.
02, CHCl3). IRνmax (film) cm −1 : 1720 (C
=O), 1460, 1375, 1360. 1H-NMR (CDCl3) δ: 0.70-1.8
4(m, 31H), 2.13(s, 3H, C(1)H3
), 2.41 (br.t, 2H, J=7.3Hz, C
(3)H2). 13C-NMR (CDCl3) δ: 19.51 (q)
, 19.67 (q), 21.32 (t), 22.55 (
q), 22.64 (q), 24.35 (t), 24.7
3(t), 27.89(d), 29.67(q), 32
.. 60(d), 32.71(d), 36.42(t),
37.17(t), 37.22(t), 37.34(t
), 39.31 (t), 43.96 (t), 208.7
0(s). MSm/e: 268 (M+ 1), 250, 210, 1
24,109,95,85,71,58 (100%). High resolution MSm/e: Theoretical value C18H36O(M+): 268.2
766. Actual value
:268.2742.
【0149】実施例15:天然のフィトールからの(6
R,10R)−6,10,14−トリメチルペンタデカ
ン−2−オンの調製Example 15: (6) from natural phytol
Preparation of R,10R)-6,10,14-trimethylpentadecane-2-one
【0150】[0150]
【数16】[Math. 16]
【0151】天然のフィトール(22)(2.045g
,6.90ミリモル)のメチルアルコール(30ml)
−ジクロロメタン(15ml)混合溶液に−78℃で攪
拌下にオゾンを18分間通した。次いで、窒素ガスを1
5分間通して過剰のオゾンを追い出した後、ジメチルス
ルフィド(3.0ml,40.8ミリモル)を滴下した
。反応液を室温まで昇温し、更に4時間攪拌した。減圧
下で溶媒を留去した後、残渣をジエチルエーテルに溶解
し、飽和塩化ナトリウム水溶液で洗浄し、硫酸マグネシ
ウムで乾燥し、減圧下で溶媒を留去した。残留物をカラ
ムクロマトグラフィー(シリカゲル40g)で処理し、
ジエチルエーテル/n−ヘキサン〔1:100(v/v
)〕溶出部より無色油状のケトン体(17)(1.79
3g,97%)を得た。理化学的データは以下の通りで
ある。0151 Natural phytol (22) (2.045g
, 6.90 mmol) of methyl alcohol (30 ml)
Ozone was passed through a mixed solution of -dichloromethane (15 ml) at -78°C for 18 minutes while stirring. Next, add 1 nitrogen gas
After driving off excess ozone for 5 minutes, dimethyl sulfide (3.0 ml, 40.8 mmol) was added dropwise. The reaction solution was heated to room temperature and further stirred for 4 hours. After evaporating the solvent under reduced pressure, the residue was dissolved in diethyl ether, washed with saturated aqueous sodium chloride solution, dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was treated with column chromatography (40 g of silica gel),
Diethyl ether/n-hexane [1:100 (v/v
)] Colorless oily ketone body (17) (1.79
3g, 97%) was obtained. The physical and chemical data are as follows.
【0152】〔α〕D 26:+1.05゜(c=1.
02,CHCl3 )。[α]D 26: +1.05° (c=1.
02, CHCl3).
【0153】本例の化合物の各種スペクトルデータは実
施例14において先に合成した化合物のものと一致した
。Various spectral data of the compound of this example were consistent with that of the compound previously synthesized in Example 14.
【0154】実施例16:(6R,10R)−2−クロ
ロ−6,10,14−トリメチルペンタデカ−1−エン
の調製Example 16: Preparation of (6R,10R)-2-chloro-6,10,14-trimethylpentadec-1-ene
【0155】[0155]
【数17】[Math. 17]
【0156】5塩化リン(2.205g,10.6ミリ
モル)のトルエン(20ml)溶液に、氷冷下で攪拌下
にてケトン体(17)(2.146g,7.99ミリモ
ル)のトルエン(30ml)溶液を5分間かけて滴下し
た。室温まで昇温し、更に15分間攪拌した後、9時間
加熱還流した。再び氷冷とし、飽和炭酸水素ナトリウム
水溶液を加えて中和した後、ジエチルエーテルを用いて
希釈し、飽和塩化ナトリウム水溶液で洗浄し、硫酸マグ
ネシウムで乾燥した後、減圧下で溶媒を留去した。残留
物をカラムクロマトグラフィー(シリカゲル80g)で
処理し、ジエチルエーテル/n−ヘキサン〔1:20(
v/v)〕溶出部より無色油状のビニルクロライド体(
18)(2.280g,99%)を得た。理化学的デー
タは以下の通りである。To a solution of phosphorus pentachloride (2.205 g, 10.6 mmol) in toluene (20 ml) was added ketone body (17) (2.146 g, 7.99 mmol) in toluene (20 ml) under stirring under ice cooling. 30 ml) solution was added dropwise over 5 minutes. After raising the temperature to room temperature and stirring for an additional 15 minutes, the mixture was heated under reflux for 9 hours. The mixture was cooled on ice again, neutralized by adding a saturated aqueous sodium bicarbonate solution, diluted with diethyl ether, washed with a saturated aqueous sodium chloride solution, dried over magnesium sulfate, and then the solvent was distilled off under reduced pressure. The residue was treated with column chromatography (80 g of silica gel) and diluted with diethyl ether/n-hexane [1:20 (
v/v)] Colorless oily vinyl chloride (
18) (2.280 g, 99%) was obtained. The physical and chemical data are as follows.
【0157】〔α〕D 31:−0.39゜(c=1.
02,CHCl3 )。
IRnmax(film)cm −1 :1670,1
635,1470,1465,1380,880。
1H−NMR(CDCl3 )δ:0.70−1.7
8(m,31H),1.90−2.44(m,2H,C
(3)H2 ),5.05−5.20(m,2H,C(
1)H2 )。
MSm/e:288(M*+ ),286(M+ ),
218,216,165,146,126,111,9
5,83,71 57(100%)。
高分解MSm/e:
理論値 C18H3637Cl(M*+ ):2
88.2397。
実測値
:288.2421。
理論値 C18H3635Cl(M+ ) :
286.2427。
実測値
:286.2410。[α]D 31: -0.39° (c=1.
02, CHCl3). IRnmax (film) cm −1 :1670,1
635, 1470, 1465, 1380, 880. 1H-NMR (CDCl3) δ: 0.70-1.7
8 (m, 31H), 1.90-2.44 (m, 2H, C
(3) H2 ), 5.05-5.20(m, 2H, C(
1)H2). MSm/e: 288 (M*+), 286 (M+),
218, 216, 165, 146, 126, 111, 9
5,83,71 57 (100%). High resolution MSm/e: Theoretical value C18H3637Cl (M**): 2
88.2397. Actual value
:288.2421. Theoretical value C18H3635Cl (M+):
286.2427. Actual value
:286.2410.
【0158】実施例17:(6R,10R)−6,10
,14−トリメチルペンタデカ−1−インの調製Example 17: (6R,10R)-6,10
, 14-trimethylpentadeca-1-yne preparation
【01
59】01
59]
【数18】[Math. 18]
【0160】ジイソプロピルアミン(4.00ml,2
9.2ミリモル)のテトラヒドロフラン(30ml)溶
液に氷冷下で攪拌下にn−ブチルリチウム(1.40M
ヘキサン溶液;22.0ml,30.8ミリモル)を加
えた。20分後、−25℃まで冷却し、ビニクロライド
体(18)(2.286g,7.97ミリモル)のテト
ラヒドロフラン(30ml)溶液を5分間かけて滴下し
た後、室温まで昇温し、4時間攪拌した。再び氷冷とし
、飽和塩化アンモニウム水溶液を加えた後、再び室温ま
で昇温した。ジエチルエーテルを用いて希釈し、飽和塩
化ナトリウム水溶液で洗浄し、硫酸マグネシウムで乾燥
した後、減圧下で溶媒を留去した。残留物をカラムクロ
マトグラフィー(シリカゲル80g)で処理し、n−ヘ
キサン溶出部より無色油状のアセチレン体(19)(1
.586g;79%)を得た。理化学的データは以下の
通りである。Diisopropylamine (4.00ml, 2
9.2 mmol) in tetrahydrofuran (30 ml) was stirred under ice cooling and n-butyllithium (1.40 M
A hexane solution (22.0 ml, 30.8 mmol) was added. After 20 minutes, the mixture was cooled to -25°C, and a solution of vinylchloride compound (18) (2.286 g, 7.97 mmol) in tetrahydrofuran (30 ml) was added dropwise over 5 minutes, and then heated to room temperature for 4 hours. Stirred. The mixture was cooled on ice again, and after adding a saturated aqueous ammonium chloride solution, the temperature was raised to room temperature again. After diluting with diethyl ether, washing with saturated aqueous sodium chloride solution and drying over magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was treated with column chromatography (80 g of silica gel), and a colorless oily acetylene compound (19) (1
.. 586g; 79%) was obtained. The physical and chemical data are as follows.
【0161】〔α〕D 29:−0.66゜(c=1.
03,CHCl3 )。
IRνmax(film)cm −1 :3315,2
130,1470,1460,1380,1375。
1H−NMR(CDCl3 )δ:0.70−1.7
5(m,31H),1.94(t,1H,J=2.7H
z,C(1)H),2.00−2.32(m,2H,C
(3)H2 )。[α]D 29: -0.66° (c=1.
03, CHCl3). IRνmax (film) cm −1 :3315,2
130, 1470, 1460, 1380, 1375. 1H-NMR (CDCl3) δ: 0.70-1.7
5 (m, 31H), 1.94 (t, 1H, J=2.7H
z, C(1)H), 2.00-2.32(m, 2H, C
(3)H2).
【0162】実施例18:(7R,11R)−7.11
.15−トリメチルヘキサデカ−2−イン−1−オール
調製Example 18: (7R,11R)-7.11
.. Preparation of 15-trimethylhexadec-2-yn-1-ol
【0163】[0163]
【数19】[Math. 19]
【0164】アセチレン体(19)(1.349g,5
.39ミリモル)のテトラヒドロフラン(20ml)溶
液に氷冷下で攪拌下にてブロモマグネシウムエチル(3
.0Mエーテル溶液;3.60ml,10.8ミリモル
)を加えた後、室温まで昇温した。3時間後に、パラホ
ルムアルデヒド(911mg,30.3ミリモル)を加
え、更に19時間攪拌した。ジエチルエーテルを用いて
希釈しし、飽和塩化ナトリウム水溶液で洗浄し,硫酸マ
グネシウムで乾燥した後、減圧下で溶媒を留去した。残
留物をカラムクロマトグラフィー(シリカゲル60g)
で処理し、ジエチルエーテル/n−ヘキサン〔1:6(
v/v)〕溶出部より原料のアセチレン体及び無色油状
のアセチレン体(20)(1103g,73%)を得た
。理化学的データは以下の通りである。Acetylene body (19) (1.349g, 5
.. To a solution of 39 mmol) in tetrahydrofuran (20 ml) was added bromomagnesium ethyl (3
.. After adding a 0M ether solution (3.60 ml, 10.8 mmol), the temperature was raised to room temperature. After 3 hours, paraformaldehyde (911 mg, 30.3 mmol) was added and stirred for an additional 19 hours. After diluting with diethyl ether, washing with saturated aqueous sodium chloride solution and drying over magnesium sulfate, the solvent was distilled off under reduced pressure. Column chromatography of the residue (60 g of silica gel)
diethyl ether/n-hexane [1:6 (
v/v)] The raw material acetylene compound and colorless oily acetylene compound (20) (1103 g, 73%) were obtained from the eluate. The physical and chemical data are as follows.
【0165】〔α〕D 26:−2.14゜(c=1.
09,CHCl3 )。
IRνmax(film)cm −1 :3372,2
224,1462,1378,1138,1013。
1H−NMR(CDCl3 )δ:0.65−1.8
0(m,32H,1H,D2 Oで交換可能),2.0
0−2.32(m,2H,C(4)H2 ),4.25
(dt,2H,J=5.9Hz,2.2Hz,C(1)
H2 )。
MSm/e:294(M+ −CH2 OH),177
,149,135,125,107,97,83,69
,57(100%)。
高分解MSm/e:
理論値 C18H33(M+ −CH2 OH)
:249.2582。
実測値
:249.2569。[α]D 26: -2.14° (c=1.
09, CHCl3). IRνmax (film) cm −1 :3372,2
224, 1462, 1378, 1138, 1013. 1H-NMR (CDCl3) δ: 0.65-1.8
0 (can be replaced with m, 32H, 1H, D2 O), 2.0
0-2.32 (m, 2H, C(4)H2), 4.25
(dt, 2H, J=5.9Hz, 2.2Hz, C(1)
H2). MSm/e: 294 (M+ -CH2OH), 177
,149,135,125,107,97,83,69
, 57 (100%). High resolution MSm/e: Theoretical value C18H33 (M+ -CH2 OH)
:249.2582. Actual value
:249.2569.
【0166】実施例19:(7R,11R)−3−ヨー
ド−7,11,15−トリメチルヘキサデカ−2−エン
−1−オールの調製Example 19: Preparation of (7R,11R)-3-iodo-7,11,15-trimethylhexadec-2-en-1-ol
【0167】[0167]
【数20】[Math. 20]
【0168】アルコール体(20)(201mg,71
7ミリモル)のジエチルエーテル(2.0ml)溶液に
氷冷下で攪拌下にてナトリウム−ビス(2−メトキシエ
トキシ)アルミニウムヒドリド(70%トルエン溶液;
0.50ml,1.73ミリモル)を加えた。10分後
に室温まで昇温し、更に13.5時間攪拌した。再び氷
冷とし、酢酸エチル(53ml,543ミリモル)を加
え、更に15分間攪拌した後、−78℃に冷却し、ヨウ
素(358mg,1.41ミリモル)を加え、直ちに室
温まで昇温し、1.5時間攪拌した。再度氷冷とし、飽
和水酸化アンモニウム水溶液を滴下し,過剰の試薬及び
複合体を分解した。セライろ過後、ジエチルエーテルで
希釈し、飽和炭酸水素ナトリウム水溶液、5%チオ硫酸
ナトリウム水溶液及び飽和塩化ナトリウム水溶液で洗浄
し,硫酸マグネシウムで乾燥した後、減圧下で溶媒を留
去した。
残留物をカラムクロマトグラフィー(シリカゲル10g
)で処理し、ジエチルエーテル/n−ヘキサン〔1:1
0(v/v)〕溶出部より無色油状のヨード体(21)
(238mg,81%)を得た。理化学的データは以下
の通りである。Alcohol compound (20) (201 mg, 71
Sodium-bis(2-methoxyethoxy)aluminum hydride (70% toluene solution;
0.50 ml, 1.73 mmol) was added. After 10 minutes, the temperature was raised to room temperature, and the mixture was further stirred for 13.5 hours. Cooled on ice again, added ethyl acetate (53 ml, 543 mmol), stirred for an additional 15 minutes, cooled to -78°C, added iodine (358 mg, 1.41 mmol), and immediately warmed to room temperature for 1 Stirred for .5 hours. The mixture was cooled on ice again, and a saturated aqueous ammonium hydroxide solution was added dropwise to decompose the excess reagent and complex. After filtering through Celite, it was diluted with diethyl ether, washed with a saturated aqueous sodium bicarbonate solution, a 5% aqueous sodium thiosulfate solution, and a saturated aqueous sodium chloride solution, dried over magnesium sulfate, and then the solvent was distilled off under reduced pressure. The residue was purified by column chromatography (10 g of silica gel).
) and diethyl ether/n-hexane [1:1
0 (v/v)] Colorless oily iodo compound (21) from the eluate
(238 mg, 81%) was obtained. The physical and chemical data are as follows.
【0169】〔α〕D 27:−2.44゜(c=1.
06,CHCl3 )。
IRνmax(film)cm −1 :3324,1
645,1461。
1H−NMR(CDCl3 )δ:0.70−1.7
6(m,32H,1H,D2 Oで交換可能),2.4
8(br.t,2H,J=7.1Hz,C(4)H2
),4.20(br.d,2H,J=5.9Hz,C(
1)H2 ),5.84(tt,J=3.9,1.2H
z,C(2)H)。
MSm/e:408(M+ ),281,198,13
7,123,109,95,83,69,57(100
%)。
高分解MSm/e:
理論値 C19H37OI(M+ ):408.
1889。
実測値
:408.1863。[α]D 27: -2.44° (c=1.
06, CHCl3). IRνmax (film) cm −1 :3324,1
645,1461. 1H-NMR (CDCl3) δ: 0.70-1.7
6 (m, 32H, 1H, exchangeable with D2O), 2.4
8(br.t, 2H, J=7.1Hz, C(4)H2
), 4.20(br.d, 2H, J=5.9Hz, C(
1) H2 ), 5.84 (tt, J=3.9, 1.2H
z, C(2)H). MSm/e: 408 (M+), 281, 198, 13
7,123,109,95,83,69,57 (100
%). High resolution MSm/e: Theoretical value C19H37OI (M+): 408.
1889. Actual value
:408.1863.
【0170】実施例20:フィトールの調製Example 20: Preparation of phytol
【0171
】0171
]
【数21】[Math. 21]
【0172】ヨウ化銅(504mg,2.65ミリモル
)のジエチルエーテル(5.0ml)懸濁液に−38℃
にて攪拌下でメチルリチウム(1.40Mジエチルエー
テル溶液;3.80ml,5.32ミリモル)を加えた
。60分後、ヨード体(21)(180mg,441ミ
リモル)のジエチルエーテル(4.5ml)溶液を5分
間かけて滴下し、更に同温下で1.5時間攪拌した。反
応液を氷冷とし、1.5時間攪拌した後、室温まで昇温
し、更に18時間攪拌した。再び氷冷とし、飽和塩化ア
ンモニウム水溶液を加えた後、室温まで昇温した。セラ
イトろ過した後、有機層を分取し、更に水層からジエチ
ルエーテルを用いて抽出した。有機層を一緒にし、飽和
塩化ナトリウム水溶液で洗浄し,硫酸マグネシウムで乾
燥した後、減圧下で溶媒を留去した。残留物をカラムク
ロマトグラフィー(シリカゲル10g)で処理し、ジエ
チルエーテル/n−ヘキサン〔1:6(v/v)〕溶出
部より無色油状のフィトール体(22)(109mg,
83%)を得た。理化学的データは以下の通りである。A suspension of copper iodide (504 mg, 2.65 mmol) in diethyl ether (5.0 ml) was heated at -38°C.
Methyllithium (1.40 M diethyl ether solution; 3.80 ml, 5.32 mmol) was added under stirring. After 60 minutes, a solution of iodo compound (21) (180 mg, 441 mmol) in diethyl ether (4.5 ml) was added dropwise over 5 minutes, and the mixture was further stirred at the same temperature for 1.5 hours. The reaction solution was ice-cooled and stirred for 1.5 hours, then warmed to room temperature and further stirred for 18 hours. The mixture was cooled on ice again, and after adding a saturated aqueous ammonium chloride solution, the temperature was raised to room temperature. After filtering through Celite, the organic layer was separated, and the aqueous layer was further extracted using diethyl ether. The organic layers were combined, washed with saturated aqueous sodium chloride solution, dried over magnesium sulfate, and then the solvent was distilled off under reduced pressure. The residue was treated with column chromatography (10 g of silica gel), and the phytol compound (22) (109 mg,
83%). The physical and chemical data are as follows.
【0173】〔α〕D 24:−1.50゜(c=0.
94,CHCl3 )〔天然の標品:〔α〕D 29:
−1.35゜(c=1.00,CHCl3 )〕。
IRνmax(film)cm −1 :3340,1
460,1375,1000。
1H−NMR(CDCl3 )δ:0.70−1.8
0(m,35H,1H,D2 Oで交換可能),1.8
5−2.15(m,C(4)H2 ),4.00−4.
30(m,2H,C(1)H2),5.23−5.57
(m,1H,C(2)H)。
13C−NMR(CDCl3 )δ:16.14(q)
,19.72(q),19.75(q),22.63(
q),22.73(q),24.59(t),24.8
2(t),25.18(t),27.98(d),32
.71(d),32.80(d),36.73(t),
37.32(t),37.40(t),37.46(t
),39.39(t),39.19(t),59.16
(t),123.34(d),139.63(s)。
MSm/e:297(M+ +1),296(M+ )
,278,196,123,71(100%)。
高分解MSm/e:
理論値 C20H40O(M+ ):296.3
079。
実測値
:296.3082。
本例の化合物の各種スペクトルデータは天然の標品のも
のと一致した。[α]D 24: -1.50° (c=0.
94, CHCl3) [Natural standard: [α]D 29:
-1.35° (c=1.00, CHCl3)]. IRνmax (film) cm −1 :3340,1
460,1375,1000. 1H-NMR (CDCl3) δ: 0.70-1.8
0 (m, 35H, 1H, exchangeable with D2 O), 1.8
5-2.15 (m, C(4)H2), 4.00-4.
30 (m, 2H, C(1)H2), 5.23-5.57
(m, 1H, C(2)H). 13C-NMR (CDCl3) δ: 16.14 (q)
, 19.72 (q), 19.75 (q), 22.63 (
q), 22.73 (q), 24.59 (t), 24.8
2(t), 25.18(t), 27.98(d), 32
.. 71(d), 32.80(d), 36.73(t),
37.32(t), 37.40(t), 37.46(t
), 39.39 (t), 39.19 (t), 59.16
(t), 123.34(d), 139.63(s). MSm/e: 297 (M+ +1), 296 (M+)
, 278, 196, 123, 71 (100%). High resolution MSm/e: Theoretical value C20H40O (M+): 296.3
079. Actual value
:296.3082. Various spectral data of the compound of this example were consistent with that of the natural standard.
【0174】実施例21:(6R,10R)−6,10
,14−トリメチルペンタデカ−1−インからのフィト
ールの調製
(19) ─────→ (22)Example 21: (6R,10R)-6,10
Preparation of phytol from ,14-trimethylpentadec-1-yne (19) ──────→ (22)
【0175】ジ
ルコノセンジクロライド(91.7mg,314μモル
)のジクロロメタン(1.0ml)懸濁液に氷冷下で攪
拌下にトリメチルアルミニウム(1.96Mジクロロメ
タン溶液;1.00ml,1.96ミリモル)を加えた
後、室温まで昇温し、更に3分間攪拌した。アセチレン
体(19)(97.0mg,387μモル)のジクロロ
メタン(3.0ml)溶液を2分間かけて滴下した後、
更に12.5時間攪拌した。減圧下で溶媒及び過剰のト
リメチルアルミニウムを留去した後、残渣をn−ヘキサ
ン(1.0ml×3)に溶解し、カニューレを用いてデ
カンテーションした。n−ヘキサン層を約1/3に濃縮
した後、テトラヒドロフラン(2.0ml)を加え、−
30℃に冷却した。n−ブチルリチウム(1.40Mヘ
キサン溶液;0.44ml,616μモル)を滴下し、
更に同温下で10分間攪拌し、氷冷とし、更に35分間
攪拌した。パラホルムアルデヒド(100.3mg,3
.34ミリモル)のテトラヒドロフラン(1.0ml)
溶液を滴下し、更に24時間攪拌した。氷冷とした後、
飽和塩化アンモニウム水溶液を滴下した。ジエチルエー
テルを用いて希釈し、水で洗浄し、硫酸マグネシウムで
乾燥した後、減圧下で溶媒を留去した。残留物をカラム
クロマトグラフィー(シリカゲル8.0g)で処理し、
ジエチルエーテル/n−ヘキサン〔1:8(v/v)〕
溶出部より無色油状のフィトール(48.0mg,42
%)を得た。本例の標記化合物の各種スペクトルデータ
は天然の標品のものと一致した。To a suspension of zirconocene dichloride (91.7 mg, 314 μmol) in dichloromethane (1.0 ml) was added trimethylaluminum (1.96 M dichloromethane solution; 1.00 ml, 1.96 mmol) with stirring under ice cooling. After the addition, the temperature was raised to room temperature and further stirred for 3 minutes. After dropping a solution of acetylene compound (19) (97.0 mg, 387 μmol) in dichloromethane (3.0 ml) over 2 minutes,
The mixture was further stirred for 12.5 hours. After distilling off the solvent and excess trimethylaluminum under reduced pressure, the residue was dissolved in n-hexane (1.0 ml x 3) and decanted using a cannula. After concentrating the n-hexane layer to about 1/3, tetrahydrofuran (2.0 ml) was added, and -
Cooled to 30°C. n-Butyllithium (1.40 M hexane solution; 0.44 ml, 616 μmol) was added dropwise,
The mixture was further stirred at the same temperature for 10 minutes, cooled on ice, and further stirred for 35 minutes. Paraformaldehyde (100.3 mg, 3
.. 34 mmol) in tetrahydrofuran (1.0 ml)
The solution was added dropwise and further stirred for 24 hours. After cooling on ice,
A saturated aqueous ammonium chloride solution was added dropwise. After diluting with diethyl ether, washing with water, and drying over magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was treated with column chromatography (silica gel 8.0 g),
Diethyl ether/n-hexane [1:8 (v/v)]
Colorless oily phytol (48.0 mg, 42
%) was obtained. Various spectral data of the title compound of this example were consistent with that of the natural standard.
【0176】[0176]
【発明の効果】本発明によれば、出発材料である光学活
性シトロネラールのキラリティーを保存したままで、純
度100%e.e.の新規な各種の光学活性化合物、特
には有用な中間体である、前記一般式(VI)で表され
る飽和ウンデシルアルコール化合物や前記一般式(IX
)で表されるフィトール化合物を得ることができる。ま
た、天然には存在しない(S)型のフィトールを製造す
ることもできる。According to the present invention, the chirality of the optically active citronellal as a starting material is preserved and the purity is 100% e.g. e. Various novel optically active compounds, particularly saturated undecyl alcohol compounds represented by the general formula (VI) and the general formula (IX), which are useful intermediates.
) can be obtained. It is also possible to produce (S) type phytol, which does not exist in nature.
Claims (4)
独立に炭素数1〜4個の低級アルキル基であり、R5
は一般式(I’) −C(A)=C(B)−E
(I’)(式中、Aはハロゲン原子又はBと一緒になっ
て炭素−炭素直接結合であり、Bは水素原子又はAと一
緒になって炭素−炭素直接結合であり、Eは水素原子又
は炭素数1〜4個のヒドロキシ低級アルキル基である)
で表される基であり、そして式中で*を付したキラル中
心炭素原子における立体配置はそれぞれ独立に択一的に
S−配置又はR−配置のいずれか一方の配置のみをとる
ものとする〕で表される化合物。Claim 1: General formula (I) [In the formula, R1, R2, R3 and R4 are each independently a lower alkyl group having 1 to 4 carbon atoms, and R5
is the general formula (I') -C(A)=C(B)-E
(I') (wherein A is a halogen atom or a direct carbon-carbon bond together with B, B is a hydrogen atom or a direct carbon-carbon bond together with A, and E is a hydrogen atom or a hydroxy lower alkyl group having 1 to 4 carbon atoms)
is a group represented by the formula, and the configuration at the chiral central carbon atom marked with * in the formula shall each independently and alternatively take only one of the S-configuration and R-configuration. ] A compound represented by
素数1〜4個の低級アルキル基であり、R6 はヒドロ
キシ基、保護されたヒドロキシ基又はハロゲン原子であ
り、そして式中で*を付したキラル中心炭素原子におけ
る立体配置はそれぞれ独立に択一的にS−配置又はR−
配置のいずれか一方の配置のみをとるものとする)で表
される化合物。Claim 2: General formula (II) [Formula 2] (wherein, R1, R2 and R3 are each independently a lower alkyl group having 1 to 4 carbon atoms, and R6 is a hydroxy group or a protected hydroxy group) or a halogen atom, and the configuration at the chiral central carbon atom marked with * in the formula is each independently and alternatively S-configuration or R-configuration.
A compound represented by the following configurations:
素数1〜4個の低級アルキル基であり、R7 はヒドロ
キシ基又は保護されたヒドロキシ基であり、R8 は一
般式(III’) −C(P)=C(Q)−T
(III’)(式中、Pは水素原子又はQと一緒になっ
て炭素−炭素直接結合であり、Qは水素原子又はPと一
緒になって炭素−炭素直接結合であり、Tは水素原子又
は炭素数1〜4個の低級アルキル基である)で表される
基であり、そして式中で*を付したキラル中心炭素原子
における立体配置は択一的にS−配置又はR−配置のい
ずれか一方の配置のみをとるものとする〕で表される化
合物。[Claim 3] General formula (III) [In the formula, R1, R2 and R3 are each independently a lower alkyl group having 1 to 4 carbon atoms, and R7 is a hydroxy group or a protected hydroxy group and R8 has the general formula (III') -C(P)=C(Q)-T
(III') (wherein P is a hydrogen atom or a direct carbon-carbon bond together with Q, Q is a hydrogen atom or a direct carbon-carbon bond together with P, and T is a hydrogen atom or a lower alkyl group having 1 to 4 carbon atoms), and the configuration at the chiral central carbon atom marked with * in the formula can alternatively be S-configuration or R-configuration. Compounds represented by [shall take only one of the configurations].
独立に炭素数1〜4個の低級アルキル基であり、R10
は炭素数1〜4個の低級アルコキシカルボニルメチル基
であり、そして式中で*を付したキラル中心炭素原子に
おける立体配置はそれぞれ独立に択一的にS−配置又は
R−配置のいずれか一方の配置のみをとるものとする)
で表される化合物。[Claim 4] General formula (IV) [Image Omitted] (wherein, R1, R2, R3 and R9 each independently represent a lower alkyl group having 1 to 4 carbon atoms, and R10
is a lower alkoxycarbonylmethyl group having 1 to 4 carbon atoms, and the configuration at the chiral central carbon atom marked with * in the formula is each independently and alternatively either the S-configuration or the R-configuration. )
A compound represented by
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10853591A JP3036882B2 (en) | 1991-04-12 | 1991-04-12 | Optically active dodecane derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10853591A JP3036882B2 (en) | 1991-04-12 | 1991-04-12 | Optically active dodecane derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04316523A true JPH04316523A (en) | 1992-11-06 |
JP3036882B2 JP3036882B2 (en) | 2000-04-24 |
Family
ID=14487275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10853591A Expired - Fee Related JP3036882B2 (en) | 1991-04-12 | 1991-04-12 | Optically active dodecane derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3036882B2 (en) |
-
1991
- 1991-04-12 JP JP10853591A patent/JP3036882B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3036882B2 (en) | 2000-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3494637B2 (en) | Method for producing intermediate of 19-nor-vitamin D compound | |
Marshall et al. | Synthesis of 7 (8)-desoxyasperdiol. A precursor of the cembranoid asperdiol | |
DE2635838A1 (en) | 4,5,6-TRINOR-3,7-INTER-M-PHENYLENE PROSTAGLANDIN COMPOUNDS AND METHOD FOR THEIR PRODUCTION | |
JPS6147459A (en) | 11-substituted-16-phenoxyprostatrienoic acid derivative | |
JPH0257548B2 (en) | ||
JP2696933B2 (en) | Substituted cyclic ketones and substituted cyclic enones and methods for their preparation | |
Chen et al. | Prostaglandins and congeners. 27. Synthesis of biologically active 16-halomethyl derivatives of 15-deoxy-16-hydroxyprostaglandin E2 | |
JPH04316523A (en) | Optically active dodecane derivative | |
JPH05201963A (en) | New vitamin d3 analog | |
JP4469794B2 (en) | Novel intermediate for the synthesis of vitamin D derivatives | |
JPS6244533B2 (en) | ||
US4808734A (en) | 16-cycloalkyl-7-fluoro-prostacyclins | |
JP3758707B2 (en) | (-)-Trans-coumaucine production method and novel intermediate | |
JP2765575B2 (en) | Process for producing substituted cyclopentenone and substituted cyclohexenone derivatives | |
US4535179A (en) | Synthesis of bicyclic and tricyclic 7-oxa prostaglandin endoperoxide analogs via oxypalladation of norbornadiene | |
JPH0146499B2 (en) | ||
JP2596825B2 (en) | Optically active compound | |
US5177251A (en) | Halogenated tetraenyl prostaglandin derivatives | |
JPH0920788A (en) | Vinyltin compound, its production and production of prostaglandins using the same | |
JP3021000B2 (en) | Optically active δ-lactone derivative | |
US4922032A (en) | Process for the preparation of optically active 2-methyl-1,2-hexanediols | |
JP4510300B2 (en) | A new intermediate for the synthesis of prostaglandins. | |
JPH0825942B2 (en) | Optically active compound | |
JPH0825940B2 (en) | Optically active compound | |
JPH083177A (en) | Production of ene-yne compound in the presence of lewis acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080225 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090225 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100225 Year of fee payment: 10 |
|
LAPS | Cancellation because of no payment of annual fees |